{{noteTA
|G1=Medicine
|T=zh-cn:严重急性呼吸综合症冠状病毒2变异株; zh-hk:嚴重急性呼吸綜合症冠狀病毒2變異株; zh-tw:嚴重急性呼吸道症候群冠狀病毒2型變異株;
|1=zh-cn:阿尔法; zh-hk:Alpha; zh-tw: Alpha; zh-sg: Alpha;
|2=zh-cn:贝塔; zh-hk: Beta; zh-tw:Beta; zh-sg:Beta;
|3=zh-cn:伽马; zh-hk:Gamma; zh-tw:Gamma; zh-sg:Gamma;
|4=zh-cn:德尔塔; zh-hk:Delta; zh-tw:Delta; zh-sg:Delta;
|5=zh-cn:埃塔; zh-hk:Eta; zh-tw:Eta; zh-sg:Eta;
|6=zh-cn:约塔; zh-hk:Iota; zh-tw:Iota; zh-sg:Iota;
|7=zh-cn:卡帕; zh-hk:Kappa; zh-tw:Kappa; zh-sg:Kappa;
|8=zh-cn:拉姆达; zh-hk:Lambda; zh-tw:Lambda; zh-sg:Lambda;
|9=zh-cn:西塔; zh-hk:Theta; zh-tw:Theta; zh-sg:Theta;
|10=zh-cn:泽塔; zh-hk:Zeta; zh-tw:Zeta; zh-sg:Zeta;
|11=zh-cn:艾普西隆; zh-hk:Epsilon; zh-tw:Epsilon; zh-sg:Epsilon;
|12=zh-cn:缪; zh-hk:Mu; zh-tw:Mu; zh-sg:Mu;
|13=zh-cn:奥密克戎; zh-hk:Omicron; zh-tw:Omicron; zh-sg:Omicron;
}}
{{medical}}
{{2019冠狀病毒病疫情邊欄}}
本文主要讲述'''严重急性呼吸综合症冠状病毒2变异株'''及其发生的[[错义突变|错义突变]]。

引发[[2019冠状病毒病|2019冠状病毒病]]的[[严重急性呼吸综合征冠状病毒2|严重急性呼吸综合征冠状病毒2]]（SARS-CoV-2冠状病毒）容易发生突变而产生{{tsl|en|Variant (biology)|變異株}}，关键病毒蛋白的突变即可能意味着其出现，目前已有多个变异株在世界各地形成并传播。由于病毒的[[核酸|核酸]]序列变异有可能导致[[抗原漂移|抗原漂移]]，而使得病毒得以逃避[[宿主|宿主]]的[[免疫应答|免疫应答]]，并影响[[2019冠状病毒病疫苗|疫苗]]的效力<ref>{{Cite web |url=https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(21)00136-0 |title=SARS CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera |access-date=2021-03-24 |archive-date=2021-12-08 |archive-url=https://web.archive.org/web/20211208060635/https://www.cell.com/cell-host-microbe/fulltext/S1931-3128%2821%2900136-0 |dead-url=no }}</ref>，这种现象称为{{link-en|免疫逃避|antigenic escape}}。

已有五种严重急性呼吸综合症冠状病毒2变异株被[[世界卫生组织|世界卫生组织]]認定为值得关注的变异株，它們分別為[[嚴重急性呼吸道症候群冠狀病毒2型Alpha變異株|Alpha變異株]]、[[严重急性呼吸综合征冠状病毒2贝塔变异株|Beta變異株]]、[[嚴重急性呼吸道症候群冠狀病毒2型Gamma變異株|Gamma變異株]]、[[嚴重急性呼吸道症候群冠狀病毒2型Delta變異株|Delta變異株]]以及[[嚴重急性呼吸道症候群冠狀病毒2型Omicron變異株|Omicron變異株]]。

==變異株對照表==
{| class="wikitable sortable"
! colspan="2" |最初檢出
! colspan="4" |代號
! rowspan="2" |重要突变
! rowspan="2" |传播
! colspan="3" |相对于武汉首次发现变体的临床变化
|-
! style="width:5em;" |地區
! 日期
! [[WHO|WHO]]标签<ref name="WHO variants">{{cite web |title=追踪SARS-CoV-2变体 |url=https://www.who.int/zh/activities/tracking-SARS-CoV-2-variants/tracking-SARS-CoV-2-variants |publisher=[[世界卫生组织|世界卫生组织]] |accessdate=2021-06-18 |archive-date=2021-12-14 |archive-url=https://web.archive.org/web/20211214085706/https://www.who.int/zh/activities/tracking-SARS-CoV-2-variants/tracking-SARS-CoV-2-variants |dead-url=no }}</ref>
! [[PANGOLIN|PANGO]]谱系
! {{tsl|en|Public Health England|PHE}}变种<ref name=":7">{{Cite web|title=Variants: distribution of case data, 9 July 2021|url=https://www.gov.uk/government/publications/covid-19-variants-genomically-confirmed-case-numbers/variants-distribution-of-case-data-9-july-2021|access-date=2021-07-10|website=GOV.UK|language=en|archive-date=2021-07-14|archive-url=https://web.archive.org/web/20210714175553/https://www.gov.uk/government/publications/covid-19-variants-genomically-confirmed-case-numbers/variants-distribution-of-case-data-9-july-2021|dead-url=no}}</ref>
! {{tsl|en|Nextstrain|Nextstrain}}[[演化支|分化枝]]
! [[基本傳染數|传播力]]
! [[病毒性|致命性]]
! [[抗原性|抗原性]]
|-
|{{Flag|Nigeria}}
|{{dts|2020|Aug}}<ref>{{cite web |title=Lineage B.1.1.207 |url=https://cov-lineages.org/lineage.html?lineage=B.1.1.207 |website=cov-lineages.org |accessdate=2021-07-15 |archive-date=2021-07-18 |archive-url=https://web.archive.org/web/20210718003419/https://cov-lineages.org/lineage.html?lineage=B.1.1.207 |dead-url=no }}</ref>
|—
|B.1.1.207
|—
|—
|P681H<ref name=":3">{{Cite web|last=CDC|title=Emerging SARS-CoV-2 Variants|url=https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variants.html|access-date=2021-01-04|publisher=Centers for Disease Control and Prevention|language=en-us|archive-date=2021-05-15|archive-url=https://web.archive.org/web/20210515065224/https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variants.html|dead-url=no}} {{PD-notice}}</ref>
|多国<ref>{{cite web |title=Lineage B.1.1.207 |url=https://cov-lineages.org/lineages/lineage_B.1.1.207.html |website=PANGO lineages |accessdate=2021-03-20 |archive-date=2021-01-27 |archive-url=https://web.archive.org/web/20210127172920/https://cov-lineages.org/lineages/lineage_B.1.1.207.html |dead-url=no }}</ref>
|{{risk|level=low|align=ml|无变化}}<ref name=":3" />
|{{risk|level=low|align=ml|无变化}}<ref name=":3" />
|
|-
| rowspan="2" |{{Flag|United Kingdom}}
|{{dts|2020|Sept}}<ref name="WHO variants" /><ref name="“PANGO" b.1.1.7”="" />
| rowspan="2" |Alpha{{efn-ua|name=voc|被世界卫生组织列为{{link-en|高關注變異株|Variant of concern}}}}
|[[嚴重急性呼吸道症候群冠狀病毒2型Alpha變異株|B.1.1.7]]<ref name="voc202102" />
|VOC-20DEC-01
|20I (V1)<ref>{{cite web |url=https://covariants.org/variants/20I.Alpha.V1 |title=Variant: 20I (Alpha, V1) |access-date=2021-06-28 |website=covariants.org |archive-date=2021-06-29 |archive-url=https://web.archive.org/web/20210629223222/https://covariants.org/variants/20I.Alpha.V1 |dead-url=no }}</ref>
|N501Y, 69–70del, P681H<ref name=":3" /><ref name="ECDC1">{{Cite web|last=ECDC|date=2021-01-21|title=Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA - first update|url=https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-risk-related-to-spread-of-new-SARS-CoV-2-variants-EU-EEA-first-update.pdf|archive-url=https://web.archive.org/web/20210222193149/https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-risk-related-to-spread-of-new-SARS-CoV-2-variants-EU-EEA-first-update.pdf|archive-date=2021-02-22|access-date=2021-02-02|website=[[歐洲疾病預防控制中心|歐洲疾病預防控制中心]]|dead-url=no}}</ref><ref name="CUMBMD">{{cite news | last=Gallagher | first=James | title=Coronavirus: UK variant 'may be more deadly' | work=[[英國廣播公司新聞|英國廣播公司新聞]] | date=2021-01-22 | url=https://www.bbc.com/news/health-55768627 | access-date=2021-01-22 | archive-date=2021-05-23 | archive-url=https://web.archive.org/web/20210523080035/https://www.bbc.com/news/health-55768627 | dead-url=no }}</ref>{{sfnp|Chand ''et al.''|loc="Potential impact of spike variant N501Y" (p. 6)}}
|全球<ref name="“PANGO" b.1.1.7”="">{{cite web |title=Lineage B.1.1.7 |url=https://cov-lineages.org/global_report_B.1.1.7.html |website={{tsl|en|Phylogenetic Assignment of Named Global Outbreak Lineages|PANGO lineages}} |accessdate=2021-05-31 |archive-date=2021-06-07 |archive-url=https://web.archive.org/web/20210607104037/https://cov-lineages.org/global_report_B.1.1.7.html |dead-url=no }}</ref>
|{{risk|level=high|align=ml|增高{{Estimate|82|43|130|unit=%|type=cri|prefix=sym|mini=auto}} <ref name="pmid33658326">{{cite journal | author=Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD | display-authors=etal | title=Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. | journal=Science | year=2021 | volume=372 | issue=6538 | pages= | pmid=33658326 | doi=10.1126/science.abg3055 | pmc=8128288 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33658326 | access-date=2022-04-03 | archive-date=2021-08-27 | archive-url=https://web.archive.org/web/20210827180256/https://scholar.google.com/scholar_casa?funding_source=citation_funder%3DUniversity%20of%20Kentucky%3Bcitation_funder_id%3Dhttp%3A%2F%2Fdx.doi.org%2F10.13039%2F100007472%3B&funding_source=citation_funder%3DUniversit%C3%A4t%20Bern%3Bcitation_funder_id%3Dhttp%3A%2F%2Fdx.doi.org%2F10.13039%2F100009068%3B&funding_source=citation_funder%3DUniversit%C3%A4tsspital%20Basel%3Bcitation_funder_id%3Dhttp%3A%2F%2Fdx.doi.org%2F10.13039%2F100016015%3B&funding_source=citation_funder%3DNational%20Institute%20for%20Health%20Research%3Bcitation_funder_id%3Dhttp%3A%2F%2Fdx.doi.org%2F10.13039%2F501100000272%3Bcitation_grant_number%3DNIHR200908%3B&funding_source=citation_funder%3DEuropean%20Commission%3Bcitation_funder_id%3Dhttp%3A%2F%2Fdx.doi.org%2F10.13039%2F501100000780%3Bcitation_grant_number%3D101003688%3B&funding_source=citation_funder%3DCANDU%20Owners%20Group%3Bcitation_funder_id%3Dhttp%3A%2F%2Fdx.doi.org%2F10.13039%2F501100002795%3B&funding_source=citation_funder%3DH%C3%B4pitaux%20Universitaires%20de%20Gen%C3%A8ve%3Bcitation_funder_id%3Dhttp%3A%2F%2Fdx.doi.org%2F10.13039%2F501100006388%3B&funding_source=citation_funder%3DEidgen%C3%B6ssische%20Technische%20Hochschule%20Z%C3%BCrich%3Bcitation_funder_id%3Dhttp%3A%2F%2Fdx.doi.org%2F10.13039%2F501100003006%3B&funding_source=citation_funder%3DUniversit%C3%A9%20de%20Sfax%3Bcitation_funder_id%3Dhttp%3A%2F%2Fdx.doi.org%2F10.13039%2F501100016206%3B&funding_source=citation_funder%3DUKRI%20Research%20England%3Bcitation_grant_number%3DNA%3B&funding_source=citation_funder%3DNational%20Institute%20for%20Health%20Research%20Health%20Protection%20Research%20Unit%20in%20Immunisation%3Bcitation_grant_number%3DNIHR200929%3B&funding_source=citation_funder%3DUnited%20Kingdom%20Medical%20Research%20Council%3Bcitation_grant_number%3DMC_PC_19065%3B&title=Estimated%20transmissibility%20and%20impact%20of%20SARS-CoV-2%20lineage%20B.1.1.7%20in%20England&journal_title=Science&publisher=American%20Association%20for%20the%20Advancement%20of%20Science&publication_year=2021%2F04%2F09&mjid=sci%3B372%2F6538%2Feabg3055&id=372%2F6538%2Feabg3055&issn=0036-8075&issn=1095-9203&doi=10.1126%2Fscience.abg3055&pmid=33658326&volume=372&issue=6538&article_type=Research%20Article&section=Research%20Article&access=all&author=Nicholas%20G.%20Davies&author_orcid=https%3A%2F%2Forcid.org%2F0000-0002-1740-1412&author=Sam%20Abbott&author_orcid=https%3A%2F%2Forcid.org%2F0000-0001-8057-8037&author=Rosanna%20C.%20Barnard&author_orcid=https%3A%2F%2Forcid.org%2F0000-0001-7602-0401&author=Christopher%20I.%20Jarvis&author_orcid=https%3A%2F%2Forcid.org%2F0000-0002-0812-2446&author=Adam%20J.%20Kucharski&author_orcid=https%3A%2F%2Forcid.org%2F0000-0002-6206-7134&author_orcid=https%3A%2F%2Forcid.org%2F0000-0003-0701-7860&author_orcid=https%3A%2F%2Forcid.org%2F0000-0001-5610-6080&author_orcid=https%3A%2F%2Forcid.org%2F0000-0002-7620-9340&author_orcid=https%3A%2F%2Forcid.org%2F0000-0003-4047-3411&author_orcid=https%3A%2F%2Forcid.org%2F0000-0002-1434-861X&author_orcid=https%3A%2F%2Forcid.org%2F0000-0002-7759-6805&author_orcid=https%3A%2F%2Forcid.org%2F0000-0002-4400-2257&author_orcid=https%3A%2F%2Forcid.org%2F0000-0002-7770-0537&author_orcid=https%3A%2F%2Forcid.org%2F0000-0002-3063-2098&author_orcid=https%3A%2F%2Forcid.org%2F0000-0003-3155-1561&author_orcid=https%3A%2F%2Forcid.org%2F0000-0001-6504-3253&author_orcid=https%3A%2F%2Forcid.org%2F0000-0002-0362-6717&author_orcid=https%3A%2F%2Forcid.org%2F0000-0002-2842-3406&author_orcid=https%3A%2F%2Forcid.org%2F0000-0001-6658-8255&author_orcid=https%3A%2F%2Forcid.org%2F0000-0001-5250-0558&author_orcid=https%3A%2F%2Forcid.org%2F0000-0002-9179-2917&url=http%3A%2F%2Fscience.sciencemag.org%2Fcontent%2F372%2F6538%2Feabg3055.long&pdfonly | dead-url=no }}</ref>}}
|{{risk|align=ml|''正在调查''}}
|{{risk|level=medium|align=ml|抗体中和效力略降低}}<ref name='nejm20210406'>{{Cite web |url=https://www.nejm.org/doi/full/10.1056/NEJMc2103022 |title=Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization |access-date=2021-06-04 |archive-date=2021-05-06 |archive-url=https://web.archive.org/web/20210506163607/https://www.nejm.org/doi/full/10.1056/NEJMc2103022 |dead-url=no }}</ref>
|-
|{{dts|2021|Jan}}<ref name=":7" />
|{{link-no|Lineage B.1.1.7#E484K mutation|Lineage B.1.1.7 with E484K|B.1.1.7#E484K}}<ref name=":7" />
|VOC-21FEB-02
|20I (V1)
|N501Y, 69–70del, P681H,<ref name=":3" />{{sfnp|Chand ''et al.''|2020|p=6|loc=Potential impact of spike variant N501Y}} E484K
|多國
|{{risk|align=ml|''正在调查''}}
|{{risk|align=ml|''正在调查''}}
|{{risk|align=ml|''正在调查''}}
|-
|{{Flag|Denmark}}
|{{dts|2020|Sept}}<ref name="WHO">{{cite web |url=https://www.who.int/csr/don/06-november-2020-mink-associated-sars-cov2-denmark/en/ |title=SARS-CoV-2 mink-associated variant strain – Denmark |publisher=[[世界卫生组织|世界卫生组织]] |access-date=2021-01-16 |date=2020-11-06 |archive-date=2020-11-12 |archive-url=https://web.archive.org/web/20201112034824/https://www.who.int/csr/don/06-november-2020-mink-associated-sars-cov2-denmark/en/ |dead-url=no }}</ref>
|—
|{{link-en|B.1.1.298|Cluster 5}}<ref name="NIH">{{cite web |title=Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity |url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899476/ |website=PubMed Central |access-date=2021-06-10 |date=2021-03-12 |language=en-us |archive-date=2021-12-08 |archive-url=https://web.archive.org/web/20211208060817/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899476/ |dead-url=no }}</ref>
|—
|—
|Y453F, {{nowrap|69–70deltaHV}}<ref name="SSI short report">{{Cite web|last=Lassaunière|first=Ria|date=2020-11-11|title=SARS-CoV-2 spike mutations arising in Danish mink and their spread to humans|url=https://files.ssi.dk/Mink-cluster-5-short-report_AFO2|archive-url=https://web.archive.org/web/20201110135434/https://files.ssi.dk/Mink-cluster-5-short-report_AFO2|archive-date=2020-11-10|access-date=2020-11-11|publisher=Statens Serum Institut}}</ref>
|可能灭绝<ref name="sum19nov">{{cite web |url=https://sum.dk/nyheder/2020/november/de-fleste-restriktioner-lempes-i-nordjylland |title=De fleste restriktioner lempes i Nordjylland |trans-title=most restrictions eased in North Jutland |publisher=Sundheds- og Ældreministeriet |date=2020-11-19 |access-date=2021-01-16 |quote=Sekventeringen af de positive prøver viser samtidig, at der ikke er påvist yderligere tilfælde af minkvariant med cluster 5 siden den 15. september, hvorfor Statens Serums Institut vurderer, at denne variant med stor sandsynlighed er døet ud. ("With high probability [...] died out") |archive-date=2021-01-20 |archive-url=https://web.archive.org/web/20210120062518/https://sum.dk/nyheder/2020/november/de-fleste-restriktioner-lempes-i-nordjylland |dead-url=no }}</ref>
|
|
|
|-
|{{Flag|South Africa}}
|{{dts|2020|May}}<ref name="WHO variants" />
|Beta{{efn-ua|name=voc}}
|[[嚴重急性呼吸道症候群冠狀病毒2型Beta變異株|B.1.351]]<ref name=":3" /><ref name="voc202102" />
|VOC-20DEC-02
|20H (V2)<ref>{{cite web |url=https://covariants.org/variants/20H.Beta.V2 |title=Variant: 20H (Beta, V2) |access-date=2021-07-04 |website=covariants.org |archive-date=2021-07-09 |archive-url=https://web.archive.org/web/20210709185140/https://covariants.org/variants/20H.Beta.V2 |dead-url=no }}</ref>
|N501Y, K417N, E484K<ref name=":3" /><ref name="Lowe">{{cite web|last=Lowe|first=Derek|date=2020-12-22|title=The New Mutations|url=https://blogs.sciencemag.org/pipeline/archives/2020/12/22/the-new-mutations|access-date=2020-12-23|website=In the Pipeline|publisher=[[American_Association_for_the_Advancement_of_Science|American Association for the Advancement of Science]]|quote=I should note here that there's another strain in South Africa that is bringing on similar concerns. This one has eight mutations in the Spike protein, with three of them (K417N, E484K and N501Y) that may have some functional role.|archive-date=2021-01-29|archive-url=https://web.archive.org/web/20210129073128/https://blogs.sciencemag.org/pipeline/archives/2020/12/22/the-new-mutations|dead-url=no}}</ref><ref name=":6">{{Cite journal|last1=Kupferschmidt|first1=Kai|date=2021-01-15|title=New coronavirus variants could cause more reinfections, require updated vaccines|url=https://www.sciencemag.org/news/2021/01/new-coronavirus-variants-could-cause-more-reinfections-require-updated-vaccines|access-date=2021-02-02|doi=10.1126/science.abg6028|journal=Science|publisher=American Association for the Advancement of Science|archive-date=2021-02-22|archive-url=https://web.archive.org/web/20210222193149/https://www.sciencemag.org/news/2021/01/new-coronavirus-variants-could-cause-more-reinfections-require-updated-vaccines|dead-url=no}}</ref><ref>{{Cite news|date=2021-01-06|title=Coronavirus variants and mutations: The science explained|language=en-GB|work=BBC News|url=https://www.bbc.com/news/science-environment-55404988|access-date=2021-02-02|archive-date=2021-02-22|archive-url=https://web.archive.org/web/20210222193151/https://www.bbc.com/news/science-environment-55404988|dead-url=no}}</ref><ref name=":4">{{cite press release|author=<!--Staff writer(s); no by-line.-->|title=Brief report: New Variant Strain of SARS-CoV-2 Identified in Travelers from Brazil|url=https://www.niid.go.jp/niid/images/epi/corona/covid19-33-en-210112.pdf|location=Japan|publisher=NIID (National Institute of Infectious Diseases)|date=2021-01-12|access-date=2021-01-14|archive-date=2021-01-15|archive-url=https://web.archive.org/web/20210115073539/https://www.niid.go.jp/niid/images/epi/corona/covid19-33-en-210112.pdf|dead-url=no}}</ref><ref name="ImmuneEscape">{{cite journal |last1=Kupferschmidt |first1=Kai |title=New mutations raise specter of 'immune escape' |journal=Science |date=2021-01-22 |volume=371 |issue=6527 |pages=329–330 |doi=10.1126/science.371.6527.329 |pmid=33479129 |url=https://science.sciencemag.org/content/371/6527/329 |access-date=2021-01-25 |archive-date=2021-05-13 |archive-url=https://web.archive.org/web/20210513071118/https://science.sciencemag.org/content/371/6527/329 |dead-url=no }}</ref>
|多国<ref>{{cite web |title=B.1.351 |url=https://cov-lineages.org/global_report_B.1.351.html |website=PANGO lineages |accessdate=2021-03-20 |archive-date=2021-06-09 |archive-url=https://web.archive.org/web/20210609174819/https://cov-lineages.org/global_report_B.1.351.html |dead-url=no }}</ref>
|{{risk|level=high|align=ml|增高{{Estimate|50|20|113|unit=%|type=cri|prefix=sym|mini=auto}}}}
|{{risk|level=low|align=ml|无变化}}<ref name="biotecnika">{{cite news |vauthors=Sruthi S |date=2021-02-10 |title=Notable Variants And Mutation Of SARS-CoV-2 |url=https://www.biotecnika.org/2021/02/variants-mutations-of-sars-cov-2-a-complete-list/ |work=BioTecNika |access-date=2021-03-22 |archive-date=2021-04-17 |archive-url=https://web.archive.org/web/20210417165408/https://www.biotecnika.org/2021/02/variants-mutations-of-sars-cov-2-a-complete-list/ |dead-url=no }}</ref>
|{{risk|level=veryhigh|align=ml|显著降低抗体中和效力<wbr/>}}<ref>{{cite journal |vauthors=Planas D, Bruel T, Grzelak L, etal |date=2021-04-14 |title=Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies |journal=Nature Medicine |volume=27 |issue=5 |pages=917–924 |doi=10.1038/s41591-021-01318-5 |pmid=33772244 |doi-access=free}}</ref><ref>{{cite web |url=https://www.scmp.com/news/hong-kong/health-environment/article/3130355/coronavirus-sinovac-vaccine-gives-70-cent-less |title=Coronavirus: Sinovac vaccine gives 70 per cent less protection against South African variant, but Hongkongers urged to still get jab |website=www.scmp.com |date=2021-04-20 |access-date=2021-04-20 |archive-date=2021-06-06 |archive-url=https://web.archive.org/web/20210606064627/https://www.scmp.com/news/hong-kong/health-environment/article/3130355/coronavirus-sinovac-vaccine-gives-70-cent-less |dead-url=no }}</ref><ref name='nejm20210406' /><ref name="lancet20210603"/>
|-
|{{Flag|JPN}}<br>{{Flag|Brazil}}
|{{dts|2020|Nov}}<ref name="WHO variants" />
|Gamma{{efn-ua|name=voc}}
|[[嚴重急性呼吸道症候群冠狀病毒2型Gamma變異株|P.1譜系]]<ref name="ECDC1" /><ref name="voc202102" />
|VOC-21JAN-02
|20J (V3)<ref>{{cite web |url=https://covariants.org/variants/20J.Gamma.V3 |title=Variant: 20J (Gamma, V3) |access-date=2021-06-26 |website=covariants.org |archive-date=2021-06-30 |archive-url=https://web.archive.org/web/20210630102820/https://covariants.org/variants/20J.Gamma.V3 |dead-url=no }}</ref>
|N501Y, E484K, K417T<ref name=":3" /><ref name="VFTfig5">Voloch, Carolina M.; et al. (2020). [https://www.medrxiv.org/content/10.1101/2020.12.23.20248598v1.full-text "Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil"] {{Wayback|url=https://www.medrxiv.org/content/10.1101/2020.12.23.20248598v1.full-text |date=20210302235205 }} full text (see figure 5). Retrieved 15 January 2021. {{DOI|10.1101/2020.12.23.20248598}} – via [[MedRxiv|MedRxiv]].</ref><ref name="IndyWWK">{{cite news|last=Lovett|first=Samuel|date=2021-01-14|title=What we know about the new Brazilian coronavirus variant|work=[[獨立報|獨立報]]|location=London|url=https://www.independent.co.uk/news/health/covid-japan-new-variant-brazil-latest-b1786847.html|access-date=2021-01-14|archive-date=2021-01-15|archive-url=https://web.archive.org/web/20210115010154/https://www.independent.co.uk/news/health/covid-japan-new-variant-brazil-latest-b1786847.html|dead-url=no}}</ref><ref name=":1">{{Cite web|date=2021-01-12|title=Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings|url=https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586|access-date=2021-01-23|website=Virological|language=en|archive-date=2021-05-20|archive-url=https://web.archive.org/web/20210520082806/https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586|dead-url=no}}</ref>
|美国、巴西等68国<ref>{{cite web |title=Lineage P.1 |url=https://cov-lineages.org/lineage.html?lineage=P.1 |website=cov-lineages.org |accessdate=2021-08-11 |archive-date=2022-01-06 |archive-url=https://web.archive.org/web/20220106182101/https://cov-lineages.org/lineage.html?lineage=P.1 |dead-url=no }}</ref>
|{{risk|level=veryhigh|align=ml|增高{{Estimate|161|145|174|unit=%|type=cri|prefix=sym|mini=auto}}<wbr/><ref>{{cite journal |vauthors=Coutinho RM, Marquitti FM, Ferreira LS, Borges ME, da Silva RL, Canton O, Portella TP, Lyra SP, Franco C, Plucinski MM, Lessa FC |display-authors=6 |date=2021-03-23 |title=Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant |url=https://www.medrxiv.org/content/10.1101/2021.03.03.21252706v3 |journal=[[medRxiv|medRxiv]] |type=[[Preprint|Preprint]] |doi=10.1101/2021.03.03.21252706 |page=9 |s2cid=232119656 |quote=The new variant was found to be about 2.6 times more transmissible (95% Confidence Interval (CI): 2.4–2.8) than previous circulating variant(s). ... Table 1: Summary of the fitted parameters and respective confidence intervals considering the entire period, November 1 2020-January 31, 2021 maintaining the same pathogenicity of the previous variant. Parameter: Relative transmission rate for the new variant. Estimate: 2.61. 2.5%: 2.45. 97.5%: 2.76. |access-date=2021-04-29 |archive-date=2021-05-03 |archive-url=https://web.archive.org/web/20210503200321/https://www.medrxiv.org/content/10.1101/2021.03.03.21252706v3 |dead-url=no }}</ref>{{efn-ua|Another study<ref name="cadde-p1">{{cite journal | vauthors = Faria NR, Mellan TA, Whittaker C, Claro IM, Candido DS, Mishra S, Crispim MA, Sales FC, Hawryluk I, McCrone JT, Hulswit RJ, Franco LA, Ramundo MS, de Jesus JG, Andrade PS, Coletti TM, Ferreira GM, Silva CA, Manuli ER, Pereira RH, Peixoto PS, Kraemer MU, Gaburo N, Camilo CD, Hoeltgebaum H, Souza WM, Rocha EC, de Souza LM, de Pinho MC, Araujo LJ, Malta FS, de Lima AB, Silva JD, Zauli DA, Ferreira AC, Schnekenberg RP, Laydon DJ, Walker PG, Schlüter HM, Dos Santos AL, Vidal MS, Del Caro VS, Filho RM, Dos Santos HM, Aguiar RS, Modena JL, Nelson B, Hay JA, Monod M, Miscouridou X, Coupland H, Sonabend R, Vollmer M, Gandy A, Suchard MA, Bowden TA, Pond SL, Wu CH, Ratmann O, Ferguson NM, Dye C, Loman NJ, Lemey P, Rambaut A, Fraiji NA, Carvalho MD, Pybus OG, Flaxman S, Bhatt S, Sabino EC | display-authors = 6 | title = Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil | journal = Science |volume=372 |issue=6544 |pages=815–821 | date = 2021-05-21 | issn = 0036-8075 | pmid = 33853970 | doi = 10.1126/science.abh2644 | pmc = 8139423 | quote = Within this plausible region of parameter space, P.1 can be between 1.7 and 2.4 times more transmissible (50% BCI, 2.0 median, with a 99% posterior probability of being >1) than local non-P1 lineages and can evade 21 to 46% (50% BCI, 32% median, with a 95% posterior probability of being able to evade at least 10%) of protective immunity elicited by previous infection with non-P.1 lineages, corresponding to 54 to 79% (50% BCI, 68% median) cross-immunity ... We estimate that infections are 1.2 to 1.9 times more likely (50% BCI, median 1.5, 90% posterior probability of being >1) to result in mortality in the period after the emergence of P.1, compared with before, although posterior estimates of this relative risk are also correlated with inferred cross-immunity. More broadly, the recent epidemic in Manaus has strained the city’s health care system, leading to inadequate access to medical care. We therefore cannot determine whether the estimated increase in relative mortality risk is due to P.1 infection, stresses on the Manaus health care system, or both. Detailed clinical investigations of P.1 infections are needed. | doi-access = free }}</ref> has estimated that P.1 may be {{Estimate|100|70|140|50|unit=%|type=cri|prefix=sym|mini=auto}} more transmissible.{{efn-ua|name=low-confidence}}}}}}
|{{risk|level=medium|align=ml|致命性增高{{Estimate|50|20|90|unit=%|type=cri|prefix=sym|mini=auto}} <wbr/><ref name="cadde-p1" />}}{{efn-ua|name=low-confidence|The reported [[信賴區間|confidence]] or {{link-en|credible interval}} has a low probability, so the estimated value can only be understood as possible, not certain nor likely.}}{{efn-ua|Preliminary results from a study in the Southern Region of Brazil found P.1 much more lethal for healthy young people. In groups without pre-existing conditions, the variant was found to be {{Estimate|490|220|985|unit=%|prefix=sym|mini=auto}} more lethal for men in the 20-39 age group, {{Estimate|465|190|1003|unit=%|prefix=sym|mini=auto}} more lethal for women in the 20-39 age group and {{Estimate|670|401|1083|unit=%|prefix=sym|mini=auto}} for women in the 40-59 age group.<ref>{{cite journal |vauthors=Freitas AR, Lemos DR, Beckedorff OA, Cavalcanti LP, Siqueira AM, Mello RC, Barros EN |display-authors=6 |date=2021-04-19 |title=The increase in the risk of severity and fatality rate of covid-19 in southern Brazil after the emergence of the Variant of Concern (VOC) SARS-CoV-2 P.1 was greater among young adults without pre-existing risk conditions |url=https://www.medrxiv.org/content/10.1101/2021.04.13.21255281v1 |type=[[Preprint|Preprint]] |via=medRxiv |doi=10.1101/2021.04.13.21255281 |quote=Female 20 to 39 years old, with no pre-existing risk conditions, were at risk of death 5.65 times higher in February (95% CI, 2.9-11.03; p <0.0001) and in the age group of 40 and 59 years old, this risk was 7.7 times higher (95% CI, 5.01-11.83; p <0.0001) comparing with November-December. ... The heterogeneity observed between the age groups was greater when we analyzed the subgroup of the population without preexisting risk conditions where we found that the CFR in the female sex in the second wave was 1.95 times (95% CI, 1.38-2.76) the CFR of the first wave in the population over 85 years old and was 7.7 times (95% CI, 5.01-11.83; p < 0.0001) in the population between 40 and 59 years old. In the male population without previous diseases, the CFR in the second wave was 2.18 (95% CI, 1.62-2.93) times the CFR of the first wave in the population over 85 years old and 5.9 (95% CI, 3.2-10.85; p < 0, 0001) higher in the range between 20 and 39 years old. |journal= |access-date=2021-05-27 |archive-date=2021-06-04 |archive-url=https://web.archive.org/web/20210604133705/https://www.medrxiv.org/content/10.1101/2021.04.13.21255281v1 |dead-url=no }}</ref>}}
|{{risk|level=high|align=ml|抗体中和效力降低<wbr/><ref name="ECDC1" />}}
|-
|{{Flag|India}}
|{{dts|2020|Oct}}<ref name="WHO variants" />
|Delta{{efn-ua|name=voc}}
|[[嚴重急性呼吸道症候群冠狀病毒2型變異株B.1.617譜系|B.1.617.2]]<ref name="PANGO_B1.617" />
|VOC-21APR-02
|21A<ref>{{cite web |url=https://covariants.org/variants/21A.Delta |title=Variant: 21A (Delta) |access-date=2021-06-29 |website=covariants.org |archive-date=2021-07-29 |archive-url=https://web.archive.org/web/20210729213814/https://covariants.org/variants/21A.Delta |dead-url=no }}</ref>
|T478K, L452R, P681R
|多国
|{{risk|level=veryhigh|增高≈{{Estimate|198|||unit=%|mini=auto}}<wbr/>{{efn-ua|About {{Estimate|64|26|113|unit=%|mini=auto}} more transmissible than the Alpha variant,<ref>{{cite techreport |type=Briefing |title=SARS-CoV-2 variants of concern and variants under investigation in England, technical briefing 15 |institution=Public Health England |date=2021-06-11 |url=https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/993879/Variants_of_Concern_VOC_Technical_Briefing_15.pdf |format=PDF |access-date=2021-06-15 |archive-date=2021-07-04 |archive-url=https://web.archive.org/web/20210704221717/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/993879/Variants_of_Concern_VOC_Technical_Briefing_15.pdf |dead-url=no }}</ref> so 1.64 × 1.82 ≈ 2.98.}}}}
|{{risk|align=ml|''正在调查''}}{{efn-ua|name=nyt20210612|相对2020年初参考病毒株，[[Delta變異株|Delta變異株]]症状发展更快、更严重<ref>{{Cite web |url=https://www.nytimes.com/2021/06/12/world/china-covid-delta-variant-guangzhou.html |title=In China's latest outbreak, doctors say the infected get sicker, faster. |access-date=2021-06-12 |archive-date=2022-03-24 |archive-url=https://web.archive.org/web/20220324073416/https://www.nytimes.com/2021/06/12/world/china-covid-delta-variant-guangzhou.html |dead-url=no }}</ref>；相對[[Alpha變異株|Alpha變異株]]，感染者住院率增加约一倍<ref>{{Cite web |url=https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01358-1/fulltext |title=SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness |access-date=2021-06-14 |archive-date=2021-06-15 |archive-url=https://web.archive.org/web/20210615075342/https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2821%2901358-1/fulltext |dead-url=no }}</ref><ref>{{Cite web |url=https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00475-8/fulltext |title=Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study |access-date=2021-08-28 |archive-date=2022-03-31 |archive-url=https://web.archive.org/web/20220331015920/https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00475-8/fulltext |dead-url=no }}</ref>。但根據英格蘭公共衛生署6月份報告，Delta變異株[[病例死亡率|病例死亡率]]累計0.2%（如只計無注射疫苗則0.13%），而舊有Alpha變異株則為1.9%<ref name=voctech>{{cite web |url=https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1001358/Variants_of_Concern_VOC_Technical_Briefing_18.pdf |title=SARS-CoV-2 variants of concern and variants under investigation in England Technical Briefing 18 |date=2021-07-09 |work=Public Health England |page=11 |access-date=2021-07-19 |language=English |archive-date=2021-07-23 |archive-url=https://web.archive.org/web/20210723004225/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1001358/Variants_of_Concern_VOC_Technical_Briefing_18.pdf |dead-url=no }}</ref>
}}
|{{risk|level=high|align=ml|抗体中和效力降低<ref name="#1">{{cite journal |last1=Yadav |first1=PD |last2=Sapkal |first2=GN |last3=Abraham |first3=P |last4=Ella |first4=R |last5=Deshpande |first5=G |last6=Patil |first6=DY |last7=Nyayanit |first7=DA |last8=Gupta |first8=N |last9=Sahay |first9=RR |last10=Shete |first10=AM |last11=Panda |first11=S |last12=Bhargava |first12=B |last13=Mohan |first13=VK |title=Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. |journal=Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |date=2021-05-07 |doi=10.1093/cid/ciab411 |pmid=33961693}}</ref><ref name="lancet20210603">{{cite journal |last1=Wall |first1=Emma C |last2=Wu |first2=Mary |last3=Harvey |first3=Ruth |last4=Kelly |first4=Gavin |last5=Warchal |first5=Scott |last6=Sawyer |first6=Chelsea |last7=Daniels |first7=Rodney |last8=Hobson |first8=Philip |last9=Hatipoglu |first9=Emine |last10=Ngai |first10=Yenting |last11=Hussain |first11=Saira |last12=Nicod |first12=Jerome |last13=Goldstone |first13=Robert |last14=Ambrose |first14=Karen |last15=Hindmarsh |first15=Steve |last16=Beale |first16=Rupert |last17=Riddell |first17=Andrew |last18=Gamblin |first18=Steve |last19=Howell |first19=Michael |last20=Kassiotis |first20=George |last21=Libri |first21=Vincenzo |last22=Williams |first22=Bryan |last23=Swanton |first23=Charles |last24=Gandhi |first24=Sonia |last25=Bauer |first25=David LV |title=Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination |journal=The Lancet |date=2021-06 |volume=397 |issue=10292 |pages=2331–2333 |doi=10.1016/S0140-6736(21)01290-3}}</ref>}}
|-
|{{Flag|US}}
|{{dts|2020|Mar}}<ref name="WHO variants" /><ref name="Pango B.1.427">{{cite web |title=Lineage B.1.427 |url=https://cov-lineages.org/lineage.html?lineage=B.1.427 |website=cov-lineages.org |accessdate=2021-07-15 |archive-date=2021-07-29 |archive-url=https://web.archive.org/web/20210729224201/https://cov-lineages.org/lineage.html?lineage=B.1.427 |dead-url=no }}</ref>
|Epsilon
|B.1.427，B.1.429<ref name="Pango B.1.427" /><ref name="Pango B.1.429 (A)">[https://cov-lineages.org/lineages/lineage_B.1.429.html Lineage B.1.429] {{Wayback|url=https://cov-lineages.org/lineages/lineage_B.1.429.html |date=20210428155149 }} ''cov-lineages.org'', accessed 19 March 2021, Graphic shows B.1.429 detected in the USA, Mexico, Canada, the UK, France, Denmark, Australia, Taiwan, Japan, South Korea, Australia, New Zealand, Guadeloupe, and Aruba</ref>
|—
|21C<ref>{{cite web |url=https://covariants.org/variants/21C.Epsilon |title=Variant: 21C (Epsilon) |access-date=2021-07-02 |website=covariants.org |archive-date=2021-07-09 |archive-url=https://web.archive.org/web/20210709182116/https://covariants.org/variants/21C.Epsilon |dead-url=no }}</ref>
|L452R<ref name="Pango B.1.429 (A)" />
|多国<ref name="Pango B.1.429 (A)" />
|{{risk|level=medium|align=ml|增高{{Estimate|20|unit=%|prefix=sym|mini=auto}} ({{val|18.6|-|24.2|u=%}})<wbr/><ref>{{cite journal | vauthors = Deng X, Garcia-Knight MA, Khalid MM, Servellita V, Wang C, Morris MK, Sotomayor-González A, Glasner DR, Reyes KR, Gliwa AS, Reddy NP, Sanchez San Martin C, Federman S, Cheng J, Balcerek J, Taylor J, Streithorst JA, Miller S, Kumar GR, Sreekumar B, Chen PY, Schulze-Gahmen U, Taha TY, Hayashi J, Simoneau CR, McMahon S, Lidsky PV, Xiao Y, Hemarajata P, Green NM, Espinosa A, Kath C, Haw M, Bell J, Hacker JK, Hanson C, Wadford DA, Anaya C, Ferguson D, Lareau LF, Frankino PA, Shivram H, Wyman SK, Ott M, Andino R, Chiu CY | display-authors = 6 | title = Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation | journal = MedRxiv | date = March 2021 | pmid = 33758899 | pmc = 7987058 | doi = 10.1101/2021.03.07.21252647 | type = [[Preprint|Preprint]] }}</ref>}}
|
|{{risk|level=high|align=ml|恢复期和疫苗接种后血清中和效力降低}}
|-
|{{Flag|Brazil}}
|{{dts|2020|Apr}}<ref name="P.2">{{cite web |title=Lineage P.2 |url=https://cov-lineages.org/lineages/lineage_P.2.html |website=PANGO lineages |accessdate=2021-06-04 |archive-date=2021-04-28 |archive-url=https://web.archive.org/web/20210428155052/https://cov-lineages.org/lineages/lineage_P.2.html |dead-url=no }}</ref>
|Zeta
|P.2
|VUI-21JAN-01
|20B/S.484K<ref>{{cite web |url=https://covariants.org/variants/S.E484 |title=Variant: S:E484 |access-date=2021-07-17 |website=covariants.org |archive-date=2021-07-19 |archive-url=https://web.archive.org/web/20210719164718/https://covariants.org/variants/S.E484 |dead-url=no }}</ref>
|E484K，D614G，V1176F<ref>{{cite web |url=https://covdb.stanford.edu/page/mutation-viewer/#sec_zeta |title=Spike Variants: Zeta variant, aka P.2 |website=covdb.stanford.edu |publisher=Stanford University Coronavirus Antiviral & Resistance Database |access-date=2021-07-18 |archive-date=2021-06-30 |archive-url=https://web.archive.org/web/20210630221011/https://covdb.stanford.edu/page/mutation-viewer/#sec_zeta |dead-url=no }}</ref>
|多国<ref name="P.2" />
|
|
|{{risk|level=medium|align=ml|单克隆抗体中和效力可能降低，疫苗接种后血清中和效力降低}}
|-
|{{Flag|英國}}<br>{{Flag|Nigeria}}
|{{dts|2020|Dec}}<ref name="WHO variants" /><ref name="B.1.525" />
|Eta
|B.1.525<ref name="Pango B.1.525">{{cite web|date=2021-02-15|title=B.1.525|url=https://cov-lineages.org/global_report_B.1.525.html|access-date=2021-02-16|work=Rambaut Group, University of Edinburgh|publisher=PANGO Lineages|archive-date=2021-06-22|archive-url=https://web.archive.org/web/20210622121437/https://cov-lineages.org/global_report_B.1.525.html|dead-url=no}}</ref>
|VUI-21FEB-03
|21D<ref>{{cite web |url=https://covariants.org/variants/21D.Eta |title=Variant: 21D (Eta) |access-date=2021-07-05 |website=covariants.org |archive-date=2021-07-31 |archive-url=https://web.archive.org/web/20210731152748/https://covariants.org/variants/21D.Eta |dead-url=no }}</ref>
|E484K, F888L<ref name="Pango B.1.525" />
|加拿大、美国、德国等69国<ref name="B.1.525">{{cite web |title=B.1.525 |url=https://cov-lineages.org/global_report_B.1.525.html |website=PANGO lineages |accessdate=2021-03-20 |archive-date=2021-06-22 |archive-url=https://web.archive.org/web/20210622121437/https://cov-lineages.org/global_report_B.1.525.html |dead-url=no }}</ref>
|
|
|{{risk|level=medium|align=ml|单克隆抗体、恢复期和疫苗接种后血清中和效力可能降低}}
|-
|{{Flag|Philippines}}
|{{dts|2021|Jan}}<ref name="WHO variants" />
|Theta
|P.3<ref name="P.3" />
|VUI-21MAR-02
|21E<ref>{{cite web |url=https://nextstrain.org/ncov/gisaid/global?branchLabel=clade&c=clade_membership |title=Genomic epidemiology of novel coronavirus - Global subsampling |access-date=2021-07-21 |website=Nextstrain |archive-date=2021-07-22 |archive-url=https://web.archive.org/web/20210722012903/https://nextstrain.org/ncov/gisaid/global?branchLabel=clade&c=clade_membership |dead-url=no }}</ref>
|E484K，N501Y，P681H，141–143[[删除_(遗传学)|del]]<ref>{{Cite news|url=https://pgc.up.edu.ph/sars-cov-2-bulletin-no-7/|title=PGC SARS-CoV-2 Bulletin No. 7: Detection and characterization of a new SARS-CoV-2 lineage P.3, with spike protein mutations E484K, N501Y, P681H and LGV 141–143 deletion, from samples sequenced through the intensified UP-PGC, UP-NIH and DOH biosurveillance program|publisher=Philippine Genome Center|date=2021-03-13|access-date=2021-06-24|archive-date=2021-05-03|archive-url=https://web.archive.org/web/20210503041041/https://pgc.up.edu.ph/sars-cov-2-bulletin-no-7/|dead-url=no}}</ref>
|菲律宾、美国等17国<ref name="P.3">{{Cite web|title=Lineage P.3|url=https://cov-lineages.org/lineages/lineage_P.3.html|access-date=2021-06-06|website=cov-lineages.org|archive-date=2021-05-05|archive-url=https://web.archive.org/web/20210505090810/https://cov-lineages.org/lineages/lineage_P.3.html|dead-url=no}}</ref>
|
|
|
|-
|{{Flag|India}}
|{{dts|2020|Oct}}<ref name="WHO variants" />
|Kappa
|[[嚴重急性呼吸道症候群冠狀病毒2型變異株B.1.617譜系|B.1.617.1]]<ref name="PANGO_B1.617">{{Cite web|title=PANGO lineages|url=https://cov-lineages.org/lineages/lineage_B.1.617.html|access-date=2021-04-17|website=cov-lineages.org|archive-date=2021-06-03|archive-url=https://web.archive.org/web/20210603085048/https://cov-lineages.org/lineages/lineage_B.1.617.html|dead-url=no}}</ref>
|VUI-21APR-01
|21B<ref>{{cite web |url=https://covariants.org/variants/21B.Kappa |title=Variant: 21B (Kappa) |access-date=2021-06-26 |website=covariants.org |archive-date=2021-07-31 |archive-url=https://web.archive.org/web/20210731172000/https://covariants.org/variants/21B.Kappa |dead-url=no }}</ref>
|E484Q, L452R, P681R<ref>{{Cite news|last=Nuki|first=Paul|last2=Newey|first2=Sarah|date=2021-04-16|title=Arrival of India’s ‘double mutation’ adds to variant woes, but threat posed remains unclear|language=en-GB|work=The Telegraph|url=https://www.telegraph.co.uk/global-health/science-and-disease/arrival-indias-double-mutation-adds-variant-woes-threat-posed/|access-date=2021-04-17|issn=0307-1235|archive-date=2021-06-21|archive-url=https://web.archive.org/web/20210621090618/https://www.telegraph.co.uk/global-health/science-and-disease/arrival-indias-double-mutation-adds-variant-woes-threat-posed/|dead-url=no}}</ref>
|多国
|
|
|{{risk|level=high|align=ml|抗体中和效力降低<ref name="#1"/>}}
|-
|{{Flag|Peru}}
|{{dts|2020|August}}<ref name="who20210615" />
|Lambda
|[[嚴重急性呼吸道症候群冠狀病毒2型Lambda變異株|C.37]]<ref name="C.37">{{Cite web|title=Lineage C.37|url=https://cov-lineages.org/lineage.html?lineage=C.37|access-date=2021-07-30|website=cov-lineages.org|archive-date=2021-07-21|archive-url=https://web.archive.org/web/20210721215307/https://cov-lineages.org/lineage.html?lineage=C.37|dead-url=no}}</ref>
|VUI-21JUN-01
|21G<ref>{{cite web |url=https://covariants.org/variants/21G.Lambda |title=Variant: 21G (Lambda) |access-date=2021-07-09 |website=covariants.org |archive-date=2021-07-21 |archive-url=https://web.archive.org/web/20210721095150/https://covariants.org/variants/21G.Lambda |dead-url=no }}</ref>
|G75V，T76I，247-253[[删除_(遗传学)|del]]，L452Q，F490S，D614G，T859N<ref>{{cite web |url=https://covdb.stanford.edu/page/mutation-viewer/#sec_lambda |title=Lambda variant, aka C.37, and B.1.1.1 sublineage in Peru and Chile |website=covdb.stanford.edu |publisher=Stanford University Coronavirus Antiviral & Resistance Database |access-date=2021-07-19 |archive-date=2021-06-30 |archive-url=https://web.archive.org/web/20210630221011/https://covdb.stanford.edu/page/mutation-viewer/#sec_lambda |dead-url=no }}</ref>
|智利、美国、祕魯等44國<ref name="C.37" />
|
|
|
|-
|{{Flag|COL}}
|2021年1月
|Mu
|[[嚴重急性呼吸道症候群冠狀病毒2型Mu變異株|B.1.621]]
|VUI-21JUL-1
|21H
|T95I、Y144S、Y145N、R346K、E484K<br>N501Y、D614G、P681H、D950N
|哥倫比亞、美國等60國
|
|
|
|-
|{{Flag|BWA}}
|2021年11月
|Omicron{{efn-ua|name=voc}}
|[[嚴重急性呼吸道症候群冠狀病毒2型Omicron變異株|B.1.1.529]]
|VUI-21NOV-1
|21K
|A67V、Δ69-70、T95I、G142D、Δ143-145、Δ211<br>L212I、ins214EPE、G339D、S371L、S373P、S375F<br>K417N、N440K、G446S、S477N、T478K、E484A<br>Q493K、G496S、Q498R、N501Y、Y505H、T547K<br>D614G、H655Y、N679K、P681H、N764K
|博茨瓦纳、南非等数国
|{{risk|level=veryhigh|有可能提高<ref name="phe-omicron-risk-assessment">{{cite techreport |type=Assessment |title=Risk assessment for SARS-CoV-2 variant Omicron |institution=Public Health England |date=22 December 2021 |url=https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043756/22-december-2021-risk-assessment-for-SARS_Omicron_VOC-21NOV-01_B.1.1.529.pdf |id=GOV-10869 |format=PDF |access-date=23 December 2021 |archive-date=2021-12-24 |archive-url=https://web.archive.org/web/20211224001846/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043756/22-december-2021-risk-assessment-for-SARS_Omicron_VOC-21NOV-01_B.1.1.529.pdf |dead-url=no }}</ref>}}
|{{risk|level=low|align=ml|<small>相对于 Delta：</small>{{Estimate|-63|69|74|unit=%|mini=yes}} <ref>{{Cite journal |last=Nyberg |first=Tommy |last2=Ferguson |first2=Neil M. |last3=Nash |first3=Sophie G. |last4=Webster |first4=Harriet H. |last5=Flaxman |first5=Seth |last6=Andrews |first6=Nick |last7=Hinsley |first7=Wes |last8=Bernal |first8=Jamie Lopez |last9=Kall |first9=Meaghan |last10=Bhatt |first10=Samir |last11=Blomquist |first11=Paula |date=2022-03-16 |title=Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study |url=https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)00462-7/abstract |journal=The Lancet |language=English |volume=0 |issue=0 |doi=10.1016/S0140-6736(22)00462-7 |issn=0140-6736 |pmid=35305296 |access-date=2022-04-03 |archive-date=2022-03-24 |archive-url=https://web.archive.org/web/20220324151137/https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)00462-7/fulltext |dead-url=no }}</ref>}}
|{{risk|level=high|align=ml|疫苗对有症状疾病的免疫效果降低<wbr/><ref name="phe-omicron-risk-assessment">{{cite techreport |type=Assessment |title=Risk assessment for SARS-CoV-2 variant Omicron |institution=Public Health England |date=22 December 2021 |url=https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043756/22-december-2021-risk-assessment-for-SARS_Omicron_VOC-21NOV-01_B.1.1.529.pdf |id=GOV-10869 |format=PDF |access-date=23 December 2021}}</ref>}}
|}
{{notelist-ua}}

== 命名法 ==
目前严重急性呼吸综合征冠状病毒2之變異株有三个常用的命名系统，分别由[[GISAID|GISAID]]、{{tsl|en|Nextstrain|Nextstrain}}和[[PANGOLIN|PANGO]]建立。<ref name="WHO variants" />

2021年5月31日，[[世界卫生组织|世界卫生组织]]宣布为重要變種病毒提供[[希臘字母|希臘字母]]标签，為免首先發現變種病毒的國家遭受[[歧視|歧視]]及[[汙名化|汙名化]]。<Ref>
{{Cite web |url=https://www.storm.mg/article/3719216 |title=不再稱印度變種、英國變種病毒！避免污名化　WHO用希臘字母命名新冠變異病毒株 風傳媒20210601 |access-date=2021-06-04 |archive-date=2021-06-04 |archive-url=https://web.archive.org/web/20210604023627/https://www.storm.mg/article/3719216 |dead-url=no }}
</Ref>其中，命名規則在[[嚴重急性呼吸道症候群冠狀病毒2型Mu變異株|Mu變異株]]後跳過了希臘字母「[[Ν|Nu]]」和「[[Ξ|Xi]]」這兩個字母。據俄羅斯官方電視台《[[RT电视台|RT]]》報導，有不具名的[[世界衛生組織|WHO]]官員透露跳過「Nu」是為避免與發音相同的「New」混淆，至於跳過「Xi」則是由於這個字母的姓氏很普遍，為了避免「對區域的汙名化」<ref>{{cite web |language= en |url= https://www.rt.com/news/541479-who-nu-xi-omicron-covid/ |title= WHO pressed to explain ‘skipping’ Nu & Xi Covid strains |date= 2021-11-26 |publisher= RT |access-date= 2021-11-28 |archive-date= 2021-11-27 |archive-url= https://web.archive.org/web/20211127202317/https://www.rt.com/news/541479-who-nu-xi-omicron-covid/ |dead-url= no }}</ref><ref>{{cite web |language= zh-tw |url= https://www.setn.com/News.aspx?NewsID=1033003 |title= 新變種病毒命名「避開Xi」！WHO官員：避免冒犯汙名化 |date= 2021-11-27 |publisher= 三立新聞網 |access-date= 2021-11-27 |archive-date= 2021-12-08 |archive-url= https://web.archive.org/web/20211208061422/https://www.setn.com/News.aspx?NewsID=1033003 |dead-url= no }}</ref><ref>{{cite web |language= zh-tw |url= https://news.ltn.com.tw/news/world/breakingnews/3749890 |title= 變異病毒Omicron命名有原因 外媒揭露為何不是Nu和Xi |date= 2021-11-27 |publisher= 自由時報 |access-date= 2021-11-27 |archive-date= 2021-12-08 |archive-url= https://web.archive.org/web/20211208061428/https://news.ltn.com.tw/news/world/breakingnews/3749890 |dead-url= no }}</ref><ref>{{cite web |language= ja |url= https://news.yahoo.co.jp/articles/68588c3200ea2e842344b7f4b8a7576e00c1d7a1 |title= ＷＨＯが中国に配慮？新変異株「ニュー」「クサイ」が飛ばされたワケ |date= 2021-11-27 |publisher= 日刊スポーツ |access-date= 2021-11-27 |archive-date= 2021-11-27 |archive-url= https://web.archive.org/web/20211127105222/https://news.yahoo.co.jp/articles/68588c3200ea2e842344b7f4b8a7576e00c1d7a1 |dead-url= no }}</ref>。

== 支序演化树 ==
[[File:Tree_diagram_of_Pango_lineages_of_SARS-CoV-2.svg|thumb]]命名系统的SARS-CoV-2谱系图]]

[[File:Prevalence_D614G.png|thumb]]<ref name="PANGO_B1"/>）逐渐成为目前全球主要传播的[[严重急性呼吸综合征冠状病毒2|严重急性呼吸综合征冠状病毒2]]类型。<ref name="D614G"/>]]
以下为严重急性呼吸综合征冠状病毒2主要变种的支序[[演化树|演化树]]简化示意图。<ref name="AlmETAL.">{{cite journal |title=Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 |year=2020 |pmc=7427299 |ref={{sfnref|Alm et al.}} |last1=Alm |first1=E. |last2=Broberg |first2=E. K. |last3=Connor |first3=T. |last4=Hodcroft |first4=E. B. |last5=Komissarov |first5=A. B. |last6=Maurer-Stroh |first6=S. |last7=Melidou |first7=A. |last8=Neher |first8=R. A.  |last9=O’Toole |first9=Áine |last10=Pereyaslov |first10=D. |author11=The WHO European Region sequencing laboratories and GISAID EpiCoV group |last12=Beerenwinkel |first12=N. |journal=[[Euro_Surveillance|Euro Surveillance]] |volume=25 |issue=32 |doi=10.2807/1560-7917.ES.2020.25.32.2001410 |pmid=32794443 |display-authors=11}}</ref>
{{clade
|label1=[[严重急性呼吸系统综合征冠状病毒2|SARS-CoV-2]]
|1={{clade
   |label1=<small>A.1–A.6</small>
   |1= [[SARS-CoV-2|WIV04/2019]]<small>（参考基因组<ref name=Zhukova>{{cite journal|last1=Zhukova|first1=Anna|last2=Blassel|first2=Luc|last3=Lemoine|first3=Frédéric|last4=Morel|first4=Marie|last5=Voznica|first5=Jakub|last6=Gascuel|first6=Olivier|title=Origin, evolution and global spread of SARS-CoV-2|url=https://comptes-rendus.academie-sciences.fr/biologies/item/CRBIOL_0__0_0_A1_0/|journal=Comptes Rendus Biologies|date=2020-11-24|pages=1–20|doi=10.5802/crbiol.29|pmid=33274614|access-date=2021-03-14|archive-date=2021-02-21|archive-url=https://web.archive.org/web/20210221205942/https://comptes-rendus.academie-sciences.fr/biologies/item/CRBIOL_0__0_0_A1_0/|dead-url=yes}}</ref>）</small>
   |label2=<small>B.1</small><ref name="D614G">'''B.1'''[[演化支|演化支]]包含有D614G[[突变|突变]]，即新冠病毒{{link-en|S蛋白|Peplomer}}的第614氨基酸位点'''D'''（[[天冬氨酸|天冬氨酸]]）到'''G'''（[[甘氨酸|甘氨酸]]）的变异。</ref>
   |2= 
{{clade
         |label1= <small>B.1.1</small>
         |1= {{clade
                 |label1= <small>B.1.1.1</small>
                 |1={{clade
                    |label1= C.1
                    |1=C.1.2 (B.1.1.1.1.2)<ref name="PANGO_B1"/><ref>{{Cite web |url=https://www.news-medical.net/news/20210826/Potential-variant-of-interest-in-South-Africa-assigned-to-the-PANGO-lineage-C12.aspx |title=Potential variant of interest in South Africa assigned to the PANGO lineage C.1.2 |access-date=2021-08-30 |archive-date=2021-12-08 |archive-url=https://web.archive.org/web/20211208061451/https://www.news-medical.net/news/20210826/Potential-variant-of-interest-in-South-Africa-assigned-to-the-PANGO-lineage-C12.aspx |dead-url=no }}</ref>
                    |label2=
                    |2={{link-no|C.36}} (B.1.1.1.36)<ref name="PANGO_B1">{{Cite web |url=https://cov-lineages.org/lineages/lineage_B.1.html |title=PANGO: Lineage B.1 |access-date=2021-06-19 |archive-date=2021-12-08 |archive-url=https://web.archive.org/web/20211208062927/https://cov-lineages.org/lineages/lineage_B.1.html |dead-url=no }}</ref>
                    |label3=
                    |3=[[嚴重急性呼吸道症候群冠狀病毒2型Lambda變異株|Lambda變異株]] (C.37谱系, B.1.1.1.37) <ref name="who20210615">{{Cite web |url=https://www.who.int/docs/default-source/coronaviruse/situation-reports/20210615_weekly_epi_update_44.pdf |title=WHO: COVID-19 Weekly Epidemiological Update, Edition 44, published 15 June 2021 |access-date=2021-06-17 |archive-date=2021-12-08 |archive-url=https://web.archive.org/web/20211208061508/https://www.who.int/docs/default-source/coronaviruse/situation-reports/20210615_weekly_epi_update_44.pdf |dead-url=no }}</ref><ref>{{Cite web |url=https://virological.org/t/novel-sublineage-within-b-1-1-1-currently-expanding-in-peru-and-chile-with-a-convergent-deletion-in-the-orf1a-gene-3675-3677-and-a-novel-deletion-in-the-spike-gene-246-252-g75v-t76i-l452q-f490s-t859n/685 |title=Novel sublineage within B.1.1.1 currently expanding in Peru and Chile, with a convergent deletion in the ORF1a gene (Δ3675-3677) and a novel deletion in the Spike gene (Δ246-252, G75V, T76I, L452Q, F490S, T859N) |access-date=2021-06-19 |archive-date=2022-01-15 |archive-url=https://web.archive.org/web/20220115025648/https://virological.org/t/novel-sublineage-within-b-1-1-1-currently-expanding-in-peru-and-chile-with-a-convergent-deletion-in-the-orf1a-gene-3675-3677-and-a-novel-deletion-in-the-spike-gene-246-252-g75v-t76i-l452q-f490s-t859n/685 |dead-url=no }}</ref><ref name="PANGO_B1"/>
                    }}
                 |label2= 
                 |2= {{clade
                     |label1= 
                     |1= [[嚴重急性呼吸道症候群冠狀病毒2型Alpha變異株|Alpha變異株]]（B.1.1.7谱系） {{efn-ua|name=voc}}
                     |label2= 
                     |2= {{link-no|带E484K的B.1.1.7谱系|Lineage B.1.1.7 with E484K|VOC-21FEB-02 (B.1.1.7#E484K)}} <ref name=":7" />{{efn-ua|name=voc|{{link-en|高關注變異株|Variant of concern}}}}
                     }}
                 |label3= <small>B.1.1.28</small>
                 |3= {{clade
                     |label1= 
                     |1=[[嚴重急性呼吸道症候群冠狀病毒2型Gamma變異株|Gamma變異株]] (P.1谱系) {{efn-ua|name=voc}}
                     |label2= 
                     |2={{link-en|P.2谱系|SARS-CoV-2 Zeta variant}} (Zeta) <ref>{{Cite web |url=https://www.france24.com/en/live-news/20210414-the-brazil-variant-what-we-know |title=The Brazil variant: what we know |access-date=2021-04-15 |archive-date=2021-12-08 |archive-url=https://web.archive.org/web/20211208061522/https://www.france24.com/en/live-news/20210414-the-brazil-variant-what-we-know |dead-url=no }}</ref>
                     |label3= 
                     |3= {{link-en|P.3谱系|SARS-CoV-2 Theta variant}} (Theta)
                     }}
                 |label4= 
                 |4= {{link-no|B.1.1.207|Lineage B.1.1.207|B.1.1.207}}
                 |label5=
                 |5= B.1.1.318 (AZ.1 - AZ.5)<ref name="PANGO_B1"/><ref name="phe-voc">{{cite web |url=https://www.gov.uk/government/publications/covid-19-variants-genomically-confirmed-case-numbers/variants-distribution-of-cases-data |title=Variants: distribution of cases data |publisher=[[Government_Digital_Service|Government Digital Service]] |website=Public Health England |access-date=16 February 2021 |archive-date=7 June 2021 |archive-url=https://web.archive.org/web/20210607111658/https://www.gov.uk/government/publications/covid-19-variants-genomically-confirmed-case-numbers/variants-distribution-of-cases-data |url-status=live }} Updated frequently. Data up to 19 May 2021 included in the 2 July 2021 update.</ref>
                 |label6= [[嚴重急性呼吸道症候群冠狀病毒2型Omicron變異株|Omicron變異株]]（B.1.1.529谱系）<ref name=news18_202201>{{Cite web |url=https://www.news18.com/news/explainers/explained-why-omicron-is-a-family-of-four-and-how-its-ba-1-sublineage-is-the-one-to-watch-out-for-4641236.html |title=EXPLAINED: Why Omicron Is A Family Of Four And How Its BA.1 Sublineage Is The One To Watch Out For |access-date=2022-01-17 |archive-date=2022-01-17 |archive-url=https://web.archive.org/web/20220117224524/https://www.news18.com/news/explainers/explained-why-omicron-is-a-family-of-four-and-how-its-ba-1-sublineage-is-the-one-to-watch-out-for-4641236.html |dead-url=no }}</ref><ref name="PANGO_B1"/><ref name="WHO_variants">{{Cite web |url=https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ |title=Tracking SARS-CoV-2 variants |access-date=2021-11-25 |archive-date=2021-06-06 |archive-url=https://web.archive.org/web/20210606183718/https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ |dead-url=no }}</ref>{{efn-ua|name=voc}}
                 |6= {{clade
                     |label1= 
                     |1=  BA.1<ref name="guardian20211207"/>
                     |label2=BA.2<ref name="guardian20211207">{{Cite web |url=https://www.theguardian.com/world/2021/dec/07/scientists-find-stealth-version-of-omicron-not-identifiable-with-pcr-test-covid-variant |title=Scientists find ‘stealth’ version of Omicron not identifiable with PCR test |access-date=2021-12-07 |archive-date=2021-12-07 |archive-url=https://web.archive.org/web/20211207163912/https://www.theguardian.com/world/2021/dec/07/scientists-find-stealth-version-of-omicron-not-identifiable-with-pcr-test-covid-variant }}</ref>
                     |2= {{clade                 
                         |label1= 
                         |1= B.2.12 (B.2.12.1)<ref>{{Cite web |last=Lee |first=Bruce Y. |title=New BA.2.12.1 Omicron Subvariant Is Even More Contagious, Fueling Covid-19 Upswing In New York State |url=https://www.forbes.com/sites/brucelee/2022/04/15/new-ba2121-omicron-subvariant-is-more-contagious-fueling-covid-19-upswing-in-new-york-state/ |access-date=2022-04-15 |website=Forbes |language=en}}</ref><ref>{{Cite news |last=Doucleff |first=Michaeleen |date=2022-04-14 |title=2 new omicron variants are spreading in N.Y. and elsewhere. Here's what we know |language=en |work=NPR |url=https://www.npr.org/sections/goatsandsoda/2022/04/14/1092812456/two-new-omicron-variants-are-spreading-in-n-y-and-elsewhere-heres-what-we-know |access-date=2022-04-15 |archive-date=2022-04-15 |archive-url=https://web.archive.org/web/20220415153605/https://www.npr.org/sections/goatsandsoda/2022/04/14/1092812456/two-new-omicron-variants-are-spreading-in-n-y-and-elsewhere-heres-what-we-know }}</ref> 
                         }}
                     |label3=
                     |3=BA.3<ref name="WHO_variants"/>
                     |label4=
                     |4=BA.4<ref name="WHO_variants"/>
                     |label5=
                     |5=BA.5<ref name="WHO_variants"/>
                     }}
              }}
         |label2= 
         |2= [[嚴重急性呼吸道症候群冠狀病毒2型Beta變異株|Beta變異株]] (Beta, B.1.351谱系) {{efn-ua|name=voc}}
         |label3= 
         |3= {{link-no|CAL.20C|California-koronavarianten}} (Epsilon, {{link-no|B.1.427|Lineage B.1.427|B.1.427}}或{{link-no|B.1.429|Lineage B.1.429|B.1.429}}) {{efn-ua|name=voc_cdc|美国疾病控制与预防中心宣布的{{link-en|引发关切的变种|Variant of concern}}}}
         |label4= 
         |4= {{link-en|B.1.525|SARS-CoV-2 Eta variant|B.1.525}} (Eta)
         |label5= 
         |5= {{link-en|B.1.526|SARS-CoV-2 Iota variant|B.1.526}} (Iota)
         |label6= <small>[[嚴重急性呼吸道症候群冠狀病毒2型變異株B.1.617譜系|B.1.617谱系]]<ref name="PANGO_B1.617"/><ref>{{cite news |url=https://www.thehindu.com/news/national/indian-double-mutant-strain-named-b1617/article34274663.ece/amp/ |title=Coronavirus: Indian 'double mutant' strain named B.1.617 |publisher=www.thehindu.com |date=2021-04-09 |access-date=2021-04-10 |archive-date=2021-05-26 |archive-url=https://web.archive.org/web/20210526012246/https://www.thehindu.com/news/national/indian-double-mutant-strain-named-b1617/article34274663.ece/amp/ |dead-url=no }}</ref><ref name="#2">{{Cite web|last=Shrutirupa|date=2021-04-17|title=IS THIS COVID – 20? {{!}} Double Mutant Strain Explained|url=https://selfimmune.com/2021/04/17/double-mutant-strain-explained/|access-date=2021-04-18|website=Self Immune|language=en-US|archive-date=2021-04-23|archive-url=https://web.archive.org/web/20210423080415/https://selfimmune.com/2021/04/17/double-mutant-strain-explained/|dead-url=no}}</ref></small>
         |6= {{clade
                     |label1=
                     |1={{link-en|B.1.617.1|SARS-CoV-2 Kappa variant}} (Kappa)
                     |label2=
                     |2={{clade
                        |label1= 
                        |1=[[嚴重急性呼吸道症候群冠狀病毒2型Delta變異株|Delta變異株]] (B.1.617.2) <ref name="PHE20210507"/>{{efn-ua|name=voc}}
                        |label2= 
                        |2={{link-de|B.1.617.2.1|B.1.617#B.1.617.2.1}} (Delta Plus, AY.1) <ref>{{Cite web |url=https://www.livemint.com/news/india/new-delta-plus-variant-of-covid-19-detected-submitted-to-global-data-system-govt-11623758268537.html |title=New "Delta Plus" variant of covid-19 detected, submitted to global-data-system: Govt |access-date=2021-06-16 |archive-date=2021-12-08 |archive-url=https://web.archive.org/web/20211208061616/https://www.livemint.com/news/india/new-delta-plus-variant-of-covid-19-detected-submitted-to-global-data-system-govt-11623758268537.html |dead-url=no }}</ref>
                        |label3= 
                        |3=B.1.617.2.4.2 (Delta Plus, AY.4.2) <ref name="PANGO_B1"/><ref>{{cite news |title=英国卫生安全局调查德尔塔毒株的一种新亚型 |url=http://www.news.cn/photo/2021-10/24/c_1127989286.htm |accessdate=2021-11-06 |archive-date=2021-12-08 |archive-url=https://web.archive.org/web/20211208061637/http://www.news.cn/photo/2021-10/24/c_1127989286.htm |dead-url=no }}</ref>
                        }}
                     |label3=
                     |3=B.1.617.3
             }}
         |label7=
         |7= {{link-no|B.1.618|Lineage B.1.618}} <ref>[https://cov-lineages.org/lineages/lineage_B.1.618.html PANGO lineages Lineage B.1.618] {{Wayback|url=https://cov-lineages.org/lineages/lineage_B.1.618.html |date=20210514093826 }} ''cov-lineages.org'', accessed 23 April 2021</ref><ref>[https://www.indiatoday.in/amp/science/story/what-is-triple-mutant-variant-of-covid19-virus-bengal-strain-details-1793991-2021-04-22 What is the new 'triple mutant variant' of Covid-19 virus found in Bengal? How bad is it?] {{Wayback|url=https://www.indiatoday.in/amp/science/story/what-is-triple-mutant-variant-of-covid19-virus-bengal-strain-details-1793991-2021-04-22 |date=20210428055736 }} ''www.indiatoday.in'', accessed 23 April 2021</ref>
         |label8=
         |8= [[嚴重急性呼吸道症候群冠狀病毒2型Mu變異株|Mu變異株]]（B.1.621譜系）<ref>{{cite web | url = https://www.ecdc.europa.eu/en/covid-19/variants-concern | title = SARS-CoV-2 variants of concern as of 11 May 2021 | date = 11 May 2021 | work = www.ecdc.europa.eu | access-date = 13 May 2021 | archive-date = 2021-06-16 | archive-url = https://web.archive.org/web/20210616103810/https://www.ecdc.europa.eu/en/covid-19/variants-concern | dead-url = no }}</ref><ref>{{Cite web |url=https://www.reuters.com/world/india/beyond-delta-scientists-are-watching-new-coronavirus-variants-2021-08-08/ |title=Explainer: Beyond Delta, scientists are watching new coronavirus variants |access-date=2021-08-08 |archive-date=2022-03-16 |archive-url=https://web.archive.org/web/20220316031113/https://www.reuters.com/world/india/beyond-delta-scientists-are-watching-new-coronavirus-variants-2021-08-08/ |dead-url=no }}</ref><ref>{{Cite web |url=https://www.medpagetoday.com/special-reports/exclusives/94077 |title=What Do We Know About B.1.621? — Variant garners attention after deadly Belgian nursing home outbreak |access-date=2021-08-18 |archive-date=2021-12-08 |archive-url=https://web.archive.org/web/20211208061729/https://www.medpagetoday.com/special-reports/exclusives/94077 |dead-url=no }}</ref><ref>{{Cite web |url=https://www.marketwatch.com/story/who-identifies-new-coronavirus-variant-of-interest-and-experts-urge-caution-on-boosters-11630509684 |title=WHO identifies new coronavirus 'variant of interest' and experts urge caution on boosters |access-date=2021-09-01 |archive-date=2021-12-08 |archive-url=https://web.archive.org/web/20211208061733/https://www.marketwatch.com/story/who-identifies-new-coronavirus-variant-of-interest-and-experts-urge-caution-on-boosters-11630509684 |dead-url=no }}</ref>
         |label9=
         |9= B.1.640 <ref>{{Cite web |url=https://www.ecdc.europa.eu/en/covid-19/variants-concern |title=SARS-CoV-2 variants of concern as of 18 November 2021 |access-date=2021-05-14 |archive-date=2021-06-16 |archive-url=https://web.archive.org/web/20210616103810/https://www.ecdc.europa.eu/en/covid-19/variants-concern |dead-url=no }}</ref><ref name="WHO_variants"/>
         }}
      }}
}}
{{notelist-ua}}

== 關注度之基準 ==
*[[世界衛生組織|世界衛生組織]]將變異株分為三個等級<ref>{{cite web |language= zh-tw |url= https://www.cna.com.tw/news/aopl/202111270103.aspx |title= Omicron變種現世 盤點5大COVID高關注變異株 |date= 2021-11-27 |publisher= 中央社 |quote= 世衛（WHO）將COVID-19變種分為3個等級，由高至低依序為：高關注變異株（Variants of Concern,VOC）、需留意變異株（Variants of Interest,VOI）、監控中變異株（Variants under Monitoring,VUM）。前兩種才另有希臘字母命名。 |access-date= 2021-11-27 |archive-date= 2021-12-08 |archive-url= https://web.archive.org/web/20211208061728/https://www.cna.com.tw/news/aopl/202111270103.aspx |dead-url= no }}</ref><ref name="voc202102">[https://jamanetwork.com/journals/jama/fullarticle/2776739?s=03 SARS-CoV-2 Variants of Concern in the United States—Challenges and Opportunities] {{Wayback|url=https://jamanetwork.com/journals/jama/fullarticle/2776739?s=03 |date=20210419040027 }} 17 February 2021, ''jamanetwork.com'', accessed 5 March 2021</ref>{{NoteTag|臺灣疾管署按美國CDC定義分三類，稱為：需留意變異株(Variants of Interest, VOI)、高關注變異株(Variants of Concern, VOC)、高衝擊變異株(Variant of High Consequence)。}}。
#{{link-en|高關注變異株|Variant of concern}}（{{lang-en|Variant of Concern，'''VOC'''}}）
#{{link-en|需留意變異株|Variant of interest}}（{{lang-en|Variant of Interest，'''VOI'''}}）
#{{link-en|監視中變異株|variants under monitoring}}（{{lang-en|variants under monitoring，'''VUM'''}}）

== 高關注變異株（VOC）==
病毒的变异是一个自然[[随机过程|随机过程]]。病毒变种引发关切的程度取决于其导致的传染性、发病率、死亡率，及逃避检测、免疫与治疗的[[风险|风险]]。目前在世界多地引发关切的主要为最早发现于非洲南部的1種變異株，依世界卫生组织建议分别由希腊字母Omicron标记。

=== Omicron（B.1.1.529谱系）===
{{Main|嚴重急性呼吸道症候群冠狀病毒2型Omicron變異株}}
B.1.1.529變異株（WHO命名為'''Omicron'''<ref>{{Cite web |url=https://www.euronews.com/2021/11/26/who-labels-new-covid-19-variant-of-concern-names-it-omicron |title=WHO labels new COVID-19 variant 'of concern', names it Omicron |access-date=2021-11-26 |archive-date=2021-12-08 |archive-url=https://web.archive.org/web/20211208063417/https://www.euronews.com/2021/11/26/who-labels-new-covid-19-variant-of-concern-names-it-omicron |dead-url=no }}</ref><ref name="mirror">{{cite news |title=強過Delta！新變種病毒「Nu」入侵亞洲 英國衛生大臣示警：史上最糟突變 |url=https://tw.news.yahoo.com/%E5%BC%B7%E9%81%8Edelta-%E6%96%B0%E8%AE%8A%E7%A8%AE%E7%97%85%E6%AF%92-nu-%E5%85%A5%E4%BE%B5%E4%BA%9E%E6%B4%B2-%E8%8B%B1%E5%9C%8B%E8%A1%9B%E7%94%9F%E5%A4%A7%E8%87%A3%E7%A4%BA%E8%AD%A6-012332760.html |author=羅心妤 |access-date=2021-11-26 |language=zh-hant |archive-date=2021-12-16 |archive-url=https://web.archive.org/web/20211216032315/https://tw.news.yahoo.com/%E5%BC%B7%E9%81%8Edelta-%E6%96%B0%E8%AE%8A%E7%A8%AE%E7%97%85%E6%AF%92-nu-%E5%85%A5%E4%BE%B5%E4%BA%9E%E6%B4%B2-%E8%8B%B1%E5%9C%8B%E8%A1%9B%E7%94%9F%E5%A4%A7%E8%87%A3%E7%A4%BA%E8%AD%A6-012332760.html |dead-url=no }}</ref><ref name="oncc20211126">{{cite news |url=https://hk.on.cc/hk/bkn/cnt/news/20211126/bkn-20211126100351821-1126_00822_001.html |title=猛毒Nu勁過Delta　許樹昌憂疫苗效力低於4成　促禁非洲人士入境 |newspaper=[[東方日報_(香港)|東方日報 (香港)]] |date=2021-11-26 |access-date=2021-11-26 |language=zh-hk |archive-date=2021-12-08 |archive-url=https://web.archive.org/web/20211208062104/https://hk.on.cc/hk/bkn/cnt/news/20211126/bkn-20211126100351821-1126_00822_001.html |dead-url=no }}</ref>）是目前變異最多的嚴重特殊傳染性肺炎病毒。據de Oliveira教授在媒體簡報會上發佈：這個變異株有超過50個突變{{r|bbc20211125}}，而單單在刺突蛋白的突變也有32種{{r|mirror}}<ref name="dm20211125">{{cite news |url=https://www.dailymail.co.uk/news/article-10229159/South-Africa-new-red-travel-list-early-TOMORROW-fears-mutant-strain.html |title='Our scientists are deeply concerned': Sajid Javid sounds alarm over new 'worst-ever' super-mutant Covid variant that will make vaccines at least 40 per cent 'less effective' as flights are BANNED from South Africa and five other African countries |author1=Tom Pyman |author2=Connor Boyd |newspaper=[[每日郵報|Daily Mail Online]] |date=2021-11-25 |access-date=2021-11-26 |language=en |archive-date=2022-02-01 |archive-url=https://web.archive.org/web/20220201105151/https://www.dailymail.co.uk/news/article-10229159/South-Africa-new-red-travel-list-early-TOMORROW-fears-mutant-strain.html |dead-url=no }}</ref>{{r|bbc20211125}}。
*於2021年11月，在非洲南部的[[波札那|波札那]]和[[南非|南非]]發現<ref name="bbc20211125">{{cite news |url=https://www.bbc.co.uk/news/health-59418127 |title=Covid: New heavily mutated variant B.1.1.529 in South Africa raises concern |publisher=[[英國廣播公司新聞|BBC新聞]] |date=2021-11-25 |access-date=2021-11-25 |language=en |archive-date=2021-11-26 |archive-url=https://web.archive.org/web/20211126175239/https://www.bbc.co.uk/news/health-59418127 |dead-url=no }}</ref><ref name=WHO21Nov>{{cite news |url=https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ |title=Tracking SARS-CoV-2 variants (Tables: Currently designated Variants Under Monitoring -describes 529 variant as present in 'Multiple countries'- and 'Formerly monitored variants'- B.1.523 & B.1.619 Reclassified Nov 2021) |publisher=[[世界卫生组织|WHO]] |date=2021-11-25 |access-date=2021-11-25 |language=en |archive-date=2021-06-06 |archive-url=https://web.archive.org/web/20210606183718/https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ |dead-url=no }}</ref>{{r|oncc20211126}}。
*2021年11月24日，升級為「VUM」等級。
*2021年11月26日，再升級為「VOC」等級。
*目前存在變種分支亞型：BA.1（標準亞型）、BA.2、BA.3、BA.4、BA.5，總共68種分支亞型。
*目前存在重組分支：
**BA.1+BA.2：XE、XG、XH、XJ、XK、XL、XN。
**BA.1.1+BA.2：XM、XP、XQ、XR。

==== BA.2 ====
於2021年12月，在[[英國|英國]]出現，為「Omicron」亞種變異株，目前超過百個國家報告了相關序列。<ref name="guardian20211207"/>

==== XE ====
屬於「Omicron」家族之一，是「Omicron」亞種BA.1＋BA.2合體變異株。主基因為「『Omicron』BA.2」。
*2022年1月19日，在[[英國|英國]]發現。目前在英國境內，已經發現至少637人，感染到「XE」變種病毒株<ref>{{cite news|title=Omicron家族變變變 英國發現新變種「XE」|url=https://tw.news.yahoo.com/omicron%E5%AE%B6%E6%97%8F%E8%AE%8A%E8%AE%8A%E8%AE%8A-%E8%8B%B1%E5%9C%8B%E7%99%BC%E7%8F%BE%E6%96%B0%E8%AE%8A%E7%A8%AE-xe-020649728.html|accessdate=2022-04-01|archive-date=2022-04-01|archive-url=https://web.archive.org/web/20220401063315/https://tw.news.yahoo.com/omicron%E5%AE%B6%E6%97%8F%E8%AE%8A%E8%AE%8A%E8%AE%8A-%E8%8B%B1%E5%9C%8B%E7%99%BC%E7%8F%BE%E6%96%B0%E8%AE%8A%E7%A8%AE-xe-020649728.html|dead-url=no}}</ref>。
*2022年3至4月，分別傳入亞洲及歐洲等地。
==== XL ====
屬於「Omicron」家族之一，是「Omicron」亞種BA.1＋BA.2合體變異株。
*2022年2月，在[[英國|英國]]首次發現。目前在英國境內，已經發現至少66例，感染到「XL」變種病毒株。
*2022年4月12日，在[[南韓|南韓]]首次發現<ref>{{cite news|title=南韓新變異株「XL」現蹤 羅一鈞曝我國現況|url=https://udn.com/news/story/120940/6233429|accessdate=2022-04-13|archive-date=2022-05-08|archive-url=https://web.archive.org/web/20220508104049/https://udn.com/news/story/120940/6233429}}</ref>。

== 受監測的VOC譜系（VOC-LUM）==
*為Omicron亞型變異株譜系：BA.4、BA.5
*為BA.2亞系變異株：BA.2.12.1、BA.2.9.1、BA.2.11、BA.2.13

== 過去的高關注變異株（Previous VOC）==
=== Alpha（B.1.1.7谱系）===
{{Main|嚴重急性呼吸道症候群冠狀病毒2型Alpha變異株}}
B.1.1.7谱系，WHO命名为“Alpha”，又称VOC 202012/01，並称501Y.V1变种。部分與「N501Y」突變有關。有23個病毒基因變異點。
*在2020年9月，首次从英国東南方的肯特郡（Kent）所發現采集的样本中发现<ref name="Rambaut et al.">{{cite report
|title=Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations
|url=https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563
|author1=Rambaut, Andrew
|author2=Loman, Nick
|author3=Pybus, Oliver
|author4=Barclay, Wendy
|author5=Barrett, Jeff
|author6=Carabelli, Alesandro
|author7=Connor, Tom
|author8=Peacock, Tom
|author9=L. Robertson, David
|author10=Volz, Erik
|access-date=2020-12-20
|date=2020-12-19
|publisher=Written on behalf of COVID-19 Genomics Consortium UK
|archive-date=2020-12-21
|archive-url=https://web.archive.org/web/20201221015539/https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563
|dead-url=no
}}</ref>。
*2020年12月18日，升級為「VOC」等級。
*2022年3月9日，降級為「Previous VOC」等級。
*目前存在變種分支：B.1.1.7、Q.1至Q.8，總共9種。

==== B.1.1.7+E484K ====
2021年2月2日，{{tsl|en|Public Health England|英国公共卫生部}}宣布采集到少数具有E484K突变的Alpha變異株[[基因组|基因组]]<ref>{{cite report |url=https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/957504/Variant_of_Concern_VOC_202012_01_Technical_Briefing_5_England.pdf |title=Investigation of novel SARS-CoV-2 variant Variant of Concern 202012/01: Technical briefing 5 |publisher=Public Health England |date=2021-02-02 |access-date=2021-06-28 |archive-date=2021-02-02 |archive-url=https://web.archive.org/web/20210202000150/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/957504/Variant_of_Concern_VOC_202012_01_Technical_Briefing_5_England.pdf |dead-url=no }}</ref>。
==== B.1.1.7+E484Q ====
2021年6月1日，[[日本|日本]]宣布在[[神户市|神户市]]发现带有E484Q突变的Alpha變異株<ref>{{Cite web |url=https://news.ltn.com.tw/news/world/breakingnews/3554303 |title=日本發現新變異病毒株 英國變異病毒株再變異 自由時報20210601 |access-date=2021-06-01 |archive-date=2021-06-03 |archive-url=https://web.archive.org/web/20210603195145/https://news.ltn.com.tw/news/world/breakingnews/3554303 |dead-url=no }}</ref><ref>{{cite news |title=新型コロナウイルス感染症（変異株） E484Qを持つアルファ株の確認について |url=https://www.city.kobe.lg.jp/a97852/740308137919.html |accessdate=2021-06-19 |publisher=[[神户市|神户市]] |date=2021-06-04 |archive-date=2021-06-24 |archive-url=https://web.archive.org/web/20210624201009/https://www.city.kobe.lg.jp/a97852/740308137919.html |dead-url=no }}</ref>。

=== Beta（B.1.351谱系） ===
{{main|嚴重急性呼吸道症候群冠狀病毒2型Beta變異株}}
B.1.351谱系，WHO命名為「Beta」，又称501Y.V2变种。與「N501Y」、「K417N」、「E484K」突變有關，与先前的新冠病毒变种相比，501Y.V2变种的传染率增加约50%。<ref>{{cite journal |author1=Pearson CAB |author2=Russell TW |author3=Davies NG |author4=et al. |title=Estimates of severity and transmissibility of novel SARS-CoV-2 variant 501Y.V2 in South Africa |date=2021-01-11 |url=https://cmmid.github.io/topics/covid19/sa-novel-variant.html |accessdate=2021-03-25 |journal= |archive-date=2021-06-11 |archive-url=https://web.archive.org/web/20210611050847/https://cmmid.github.io/topics/covid19/sa-novel-variant.html |dead-url=no }}</ref>有证据表明，501Y.V2变种的刺突蛋白突变E484K可能会影响一些[[多克隆抗体|多克隆抗体]]和[[单克隆抗体|单克隆抗体]]的中和作用。当前尚未有证据表明该变种影響嚴重特殊傳染性肺炎的嚴重程度<ref name="CDC">{{cite web |title=Science Brief: Emerging SARS-CoV-2 Variants |url=https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variants.html |website=CDC |accessdate=2021-03-23 |archive-date=2021-05-15 |archive-url=https://web.archive.org/web/20210515065224/https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variants.html |dead-url=no }}</ref>。。
*2020年5月，在南非[[东开普省|东开普省]]的[[纳尔逊·曼德拉湾大都会自治市|纳尔逊·曼德拉湾]]发现。
*2020年12月18日，被[[南非|南非]]科学家和卫生官员报道。<ref>{{cite news |author1=Sheri Fink |title=South Africa announces a new coronavirus variant. |url=https://www.nytimes.com/2020/12/19/world/south-africa-announces-a-new-coronavirus-variant.html |accessdate=2021-03-25 |work=[[纽约时报|纽约时报]] |date=2020-12-18 |archive-date=2020-12-21 |archive-url=https://web.archive.org/web/20201221073359/https://www.nytimes.com/2020/12/19/world/south-africa-announces-a-new-coronavirus-variant.html |dead-url=no }}</ref><ref>{{cite news |title=SA reaches grim milestone of 1 million Covid-19 cases |url=https://www.iol.co.za/news/south-africa/kwazulu-natal/sa-reaches-grim-milestone-of-1-million-covid-19-cases-a01906de-5442-451c-932f-84d6fc381b84 |accessdate=2021-03-23 |publisher=Independent Online |archive-date=2021-05-26 |archive-url=https://web.archive.org/web/20210526122545/https://www.iol.co.za/news/south-africa/kwazulu-natal/sa-reaches-grim-milestone-of-1-million-covid-19-cases-a01906de-5442-451c-932f-84d6fc381b84 |dead-url=no }}</ref>
*2020年12月18日，升級為「VOC」等級。
*2022年3月9日，降級為「Previous VOC」等級。
*目前存在變種分支：B.1.351、B.1.351.1、B.1.351.2、B.1.351.3、B.1.351.4、B.1.351.5，總共6種。

=== Gamma（P.1谱系）===
{{main|嚴重急性呼吸道症候群冠狀病毒2型Gamma變異株}}
P.1谱系，WHO命名為「Gamma」，又称501Y.V3变种。包括三個相關突變：「N501Y」、「E484K」和「K417T」。
*2020年11月，在[[巴西|巴西]]发现。
*2021年1月2日，在[[东京国际机场|东京国际机场]]从四名巴西飞抵日本的旅客发现，由日本[[国立感染症研究所|国立感染症研究所]]报道<ref name="CDC" />。
*2021年1月11日，升級為「VOC」等級。
*2022年3月9日，降級為「Previous VOC」等級。
*目前存在變種分支：P.1至P.1.17.1，總共22種。

=== Delta（B.1.617.2谱系）===
{{Main|嚴重急性呼吸道症候群冠狀病毒2型變異株B.1.617譜系}}
B.1.617谱系是2020年10月于[[印度|印度]]发现的一种双突变變異株。直到2021年1月前，该變異株的感染人数都寥寥无几。4月时该變異株已经蔓延至超过20个国家，遍及南极洲和南美洲以外的所有大洲。<ref>{{Cite web|title=PANGO lineages|url=https://cov-lineages.org/lineages/lineage_B.1.617.html|access-date=2021-04-18|website=cov-lineages.org|archive-date=2021-06-03|archive-url=https://web.archive.org/web/20210603085048/https://cov-lineages.org/lineages/lineage_B.1.617.html|dead-url=no}}</ref><ref name="Koshy">{{cite news |last1=Koshy |first1=Jacob |title=Coronavirus {{!}} Indian 'double mutant' strain named B.1.617 |url=https://www.thehindu.com/news/national/indian-double-mutant-strain-named-b1617/article34274663.ece/amp/ |work=The Hindu |date=2021-04-08 |language=en |accessdate=2021-04-13 |archive-date=2021-05-26 |archive-url=https://web.archive.org/web/20210526012246/https://www.thehindu.com/news/national/indian-double-mutant-strain-named-b1617/article34274663.ece/amp/ |dead-url=no }}</ref><ref>{{cite news |url=https://torontosun.com/news/local-news/indias-variant-fuelled-second-wave-coincided-with-spike-in-infected-flights-landing-in-canada |title=India's variant-fuelled second wave coincided with spike in infected flights landing in Canada |publisher=[[Toronto_Sun|Toronto Sun]] |date=2021-04-10 |access-date=2021-04-10 |archive-date=2021-06-02 |archive-url=https://web.archive.org/web/20210602102218/https://torontosun.com/news/local-news/indias-variant-fuelled-second-wave-coincided-with-spike-in-infected-flights-landing-in-canada |dead-url=no }}</ref>

在该變異株约15个谱系定义突变中包括刺突蛋白突变D111D（{{le|同义突变|synonymous substitution}}）、G142D<ref>{{Cite web | url=https://www.biorxiv.org/content/10.1101/2021.04.22.440932v1 | title="Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India" | doi=10.1101/2021.04.22.440932 | date=2021-04-24 | access-date=2021-04-25 | archive-date=2021-05-30 | archive-url=https://web.archive.org/web/20210530190512/https://www.biorxiv.org/content/10.1101/2021.04.22.440932v1 | dead-url=no }}</ref>、P681R、E484Q<ref name="#2"/>、L452R<ref>{{cite news |url=https://www.bbc.co.uk/news/world-asia-india-56517495 |title='Double mutant': What are the risks of India's new Covid-19 variant |website=www.bbc.co.uk/news |date=2021-03-25 |access-date=2021-04-11 |archive-date=2021-04-28 |archive-url=https://web.archive.org/web/20210428080913/https://www.bbc.co.uk/news/world-asia-india-56517495 |dead-url=no }}</ref>，其中后两个突变可能会影响[[抗血清|恢复期血浆]]和[[单克隆抗体|单克隆抗体]]的中和作用。<ref>[https://www.forbes.com/sites/williamhaseltine/2021/04/12/an-indian-sars-cov-2-variant-lands-in-california-more-danger-ahead/?sh=7b8c566d3b29 Haseltine WA. An Indian SARS-CoV-2 Variant Lands In California. More Danger Ahead?] {{Wayback|url=https://www.forbes.com/sites/williamhaseltine/2021/04/12/an-indian-sars-cov-2-variant-lands-in-california-more-danger-ahead/?sh=7b8c566d3b29 |date=20210414090052 }} ''Forbes.com'', Apr 12, 2021, accessed 14 April 2021</ref>

{{link-en|英国公共卫生部|Public Health England}}于5月7日将B.1.617.2列为“{{link-en|高關注變異株|Variant of concern}}”，命名为VOC-21APR-02。<ref name="PHE20210507">{{Cite web |url=https://www.reuters.com/world/uk/public-health-england-says-coronavirus-variant-b16172-is-variant-concern-2021-05-07/ |title=Public Health England says coronavirus variant B.1.617.2 is a variant of concern |access-date=2021-05-07 |archive-date=2021-05-18 |archive-url=https://web.archive.org/web/20210518071908/https://www.reuters.com/world/uk/public-health-england-says-coronavirus-variant-b16172-is-variant-concern-2021-05-07/ |dead-url=no }}</ref><ref>{{Cite web|date=2021-05-07|title=British scientists warn over Indian coronavirus variant|url=https://www.reuters.com/world/uk/british-officials-warn-over-indian-coronavirus-variant-reports-2021-05-07/|access-date=2021-05-07|website=Reuters|archive-date=2021-05-22|archive-url=https://web.archive.org/web/20210522193242/https://www.reuters.com/world/uk/british-officials-warn-over-indian-coronavirus-variant-reports-2021-05-07/|dead-url=no}}</ref> 

5月10日[[世界卫生组织|WHO]]称，因为B.1.617较高的传染性，该变异正被列为全球范围内受关切变种<ref name="reuters20210510">[https://www.reuters.com/article/us-health-coronavirus-who-india-idUSKBN2CR1P6 WHO classifies India variant as being of global concern]</ref>。6月1日WHO将受关切变种限定为B.1.617谱系当中的B.1.617.2（Delta）变种。<ref>{{Cite web |url=https://medicalxpress.com/news/2021-06-narrows-covid-delta-variant.html |title=WHO narrows in on COVID Delta variant |access-date=2021-06-06 |archive-date=2021-06-06 |archive-url=https://web.archive.org/web/20210606143409/https://medicalxpress.com/news/2021-06-narrows-covid-delta-variant.html |dead-url=no }}</ref> 稍后WHO將B.1.617.2命名為「Delta」。

5月21日，[[越南|越南]]宣布发现一种传播性更高，由[[Delta變異株|Delta變異株]]加上[[Alpha變異株|Alpha變異株]]上突变的病毒株。<ref>{{Cite web |url=https://www.cna.com.tw/news/firstnews/202105290067.aspx |title=越南新病毒株傳染力更強 印度與英國變異株混種 中央社20210529 |access-date=2021-05-30 |archive-date=2021-06-08 |archive-url=https://web.archive.org/web/20210608081700/https://www.cna.com.tw/news/firstnews/202105290067.aspx |dead-url=no }}</ref>6月3日，[[WHO|WHO]]澄清该病毒株不符合新混合变种的定义，并将其列为带有突变的Delta变种。<ref>{{cite news |author1=Robert Hart |title=‘No New Hybrid Variant’ In Vietnam, World Health Organization Official Says |url=https://www.forbes.com/sites/roberthart/2021/06/03/no-new-hybrid-variant-in-vietnam-world-health-organization-official-says/?sh=1bbdc19a3aee |accessdate=2021-06-18 |work=[[福布斯|福布斯]] |date=2021-06-03 |archive-date=2021-06-24 |archive-url=https://web.archive.org/web/20210624200857/https://www.forbes.com/sites/roberthart/2021/06/03/no-new-hybrid-variant-in-vietnam-world-health-organization-official-says/?sh=1bbdc19a3aee |dead-url=no }}</ref>

据报道，Delta變異株[[基本传染数|基本传染数]]R0大约为6（有说法称其高达8或9）<ref>{{Cite web |url=https://www.cnn.com/2021/07/29/politics/cdc-masks-covid-19-infections/index.html |title=CDC document warns Delta variant appears to spread as easily as chickenpox and cause more severe infection |access-date=2021-08-01 |archive-date=2021-08-01 |archive-url=https://web.archive.org/web/20210801181225/https://www.cnn.com/2021/07/29/politics/cdc-masks-covid-19-infections/index.html |dead-url=no }}</ref>，是[[嚴重急性呼吸道症候群冠狀病毒2型|嚴重急性呼吸道症候群冠狀病毒2型]]原始毒株基本传染数的2倍以上。<ref>{{Cite web |url=https://www.forbes.com/sites/williamhaseltine/2021/07/13/the-delta-dilemma-loosening-covid-19-controls-at-a-time-of-increased-danger/?sh=2e1c31ca2750 |title=Delta Dilemma: Loosening Covid-19 Controls At A Time Of Increased Danger |access-date=2021-07-14 |archive-date=2021-07-14 |archive-url=https://web.archive.org/web/20210714234335/https://www.forbes.com/sites/williamhaseltine/2021/07/13/the-delta-dilemma-loosening-covid-19-controls-at-a-time-of-increased-danger/?sh=2e1c31ca2750 |dead-url=no }}</ref>
*2021年4月4日，為升級為「VOI」等級。
*2021年5月11日，為升級為「VOC」等級。
*2022年6月7日，降級為「Previous VOC」等級。

==== Delta Plus（AY.1谱系） ====
带有K417N突变的Delta變異株在2021年6月发现。<ref>{{cite news |title=India Says New 'Delta Plus' Coronavirus Variant May Be More Transmissible |url=https://www.npr.org/2021/06/23/1009582139/india-has-detected-a-more-contagious-and-vaccine-resistant-variant-delta-plus |accessdate=2021-06-26 |publisher=[[NPR|NPR]] |date=2021-06-23 |archive-date=2021-07-31 |archive-url=https://web.archive.org/web/20210731044726/https://www.npr.org/2021/06/23/1009582139/india-has-detected-a-more-contagious-and-vaccine-resistant-variant-delta-plus |dead-url=no }}</ref>该变种被称为Delta Plus，是目前具有威脅的病毒株之一。原Delta變異株已擴散到85國，Delta Plus亦有蹤跡在[[印度|印度]]外的美國、英國、葡萄牙、瑞士、日本、波蘭、尼泊爾、俄羅斯、中國、加拿大等12國。<ref>{{Cite web |url=https://newtalk.tw/news/view/2021-06-24/593733 |title=印度變種 Delta Plus 病毒高風險？ 專家：別太早判斷 新頭殼 |access-date=2021-06-25 |archive-date=2021-06-30 |archive-url=https://web.archive.org/web/20210630101346/https://newtalk.tw/news/view/2021-06-24/593733 |dead-url=no }}</ref><ref>{{Cite web |url=https://news.ltn.com.tw/news/world/breakingnews/3571184 |title=變種病毒再突變 印度Delta Plus抗藥性更強！自由時報 |access-date=2021-06-25 |archive-date=2021-06-28 |archive-url=https://web.archive.org/web/20210628034924/https://news.ltn.com.tw/news/world/breakingnews/3571184 |dead-url=no }}</ref><ref>{{Cite web |url=https://news.ltn.com.tw/news/world/breakingnews/3579137 |title=令人擔憂！ 印度Delta Plus變種病毒擴散 3邦約20人中鏢 自由時報 |access-date=2021-06-25 |archive-date=2021-06-28 |archive-url=https://web.archive.org/web/20210628051631/https://news.ltn.com.tw/news/world/breakingnews/3579137 |dead-url=no }}</ref><ref>{{Cite web |url=https://www.upmedia.mg/news_info.php?SerialNo=116982 |title=印度變種再突變　Delta Plus傳播到11國 上報 20210625 |access-date=2021-06-26 |archive-date=2021-07-03 |archive-url=https://web.archive.org/web/20210703113624/https://www.upmedia.mg/news_info.php?SerialNo=116982 |dead-url=no }}</ref><ref>{{Cite web |url=https://www.ettoday.net/news/20210626/2016436.htm |title=變種再進化「Delta+病毒」擴散12國！印度累計51例　傳播力恐更強 東森新聞雲 20210626 |access-date=2021-06-26 |archive-date=2021-06-30 |archive-url=https://web.archive.org/web/20210630092221/https://www.ettoday.net/news/20210626/2016436.htm |dead-url=no }}</ref>。2021年7月，在英國出現「AY.4.2」。
*目前存在變種分支：AY.1至AY.134，總共240種分支亞型。

== 需留意變異株(VOI) ==
目前無此等級變異株。

== 過去的需留意變異株(Previous VOI) ==
=== Epsilon（B.1.427譜系、B.1.429譜系）===
B.1.427譜系、B.1.429譜系，WHO命名為「Epsilon」，於2020年3月在[[美國|美國]][[加州|加州]]首次發現。
*2021年3月5日，升級為「VOI」等級。
*2021年7月6日，降級為「Previous VOI」等級。

=== Zeta（P.2譜系）===
P.2譜系，WHO命名為「Zeta」，於2020年4月在[[巴西|巴西]][[里約熱內盧|里約熱內盧]]首次發現。
*2021年3月17日，升級為「VOI」等級。
*2021年7月6日，降級為「Previous VOI」等級。

=== Eta（B.1.525譜系）===
B.1.525譜系，WHO命名為「Eta」，於2020年12月在[[奈及利亞|奈及利亞]]首次發現。
*2021年3月17日，升級為「VOI」等級。
*2021年9月20日，降級為「Previous VOI」等級。

=== Iota（B.1.526譜系）===
B.1.526譜系，WHO命名為「Iota」，於2020年11月在[[美國|美國]][[紐約|紐約]]首次發現。
*2021年3月20日，升級為「VOI」等級。
*2021年9月20日，降級為「Previous VOI」等級。

=== Theta（P.3譜系）===
P.3譜系，WHO命名為「Theta」，於2021年1月在[[菲律賓|菲律賓]]首次發現。
*2021年3月24日，升級為「VOI」等級。
*2021年7月6日，降級為「Previous VOI」等級。

=== Kappa（B.1.617.1）===
{{main|嚴重急性呼吸道症候群冠狀病毒2型變異株B.1.617譜系}}
B.1.617譜系的三個子譜系之一當中的「B.1.617.1」，WHO命名為「Kappa」，於2020年10月在[[印度|印度]]首次發現。
*2021年4月4日，升級為「VOI」等級。
*2021年9月20日，降級為「Previous VOI」等級。

=== Lambda（C.37谱系）===
{{main|嚴重急性呼吸道症候群冠狀病毒2型Lambda變異株}}
C.37譜系，WHO命名為「Lambda」，於2020年8月在[[秘魯|秘魯]]首次發現。
*2021年6月14日，升級為「VOI」等級。
*2022年3月9日，降級為「Previous VOI」等級。

=== Mu（B.1.621譜系）===
{{main|嚴重急性呼吸道症候群冠狀病毒2型Mu變異株}}
B.1.621譜系，WHO命名為「Mu」，於2021年1月在[[哥倫比亞|哥倫比亞]]首次發現。
*2021年8月30日，升級為「VOI」等級。
*2022年3月9日，降級為「Previous VOI」等級。

== 監視中變異株(VUM) ==
目前無此等級變異株。

== 過去的監視中變異株(FMV) ==
*AV.1	
*AT.1		
*R.1	
*B.1.466.2	
*B.1.1.519	
*C.36.3	
*B.1.214.2	
*B.1.1.523			
*B.1.619			
*B.1.620
*B.1.630
*B.1.1.318
*C.1.2
*B.1.640
*XD

== 曾經關注變異株 ==
*Cluster 5
*B.1.1.207 
*B.1.1.317
*B.1.616
*B.1.618
== 顯著的錯義突變 ==
*D614G
*del 69-70
*RSYLTPGD246-253N
*N440K
*G446V
*L452R
*Y453F
*S477G/N
*E484Q
*E484K
*E484A
*F490S
*N501Y
*N501S
*Q677P/H
*P681H
*P681R
*A701V
*Δ69–70
*ins214EPE
*nsp6:Δ106–108
*S371L/S373P

== 备注 ==
{{NoteFoot}}

== 参见 ==
*[[严重急性呼吸综合征冠状病毒2|严重急性呼吸综合征冠状病毒2]]
*[[变种|变种]]
**[[突变#错义突变|突变#错义突变]]
**{{link-en|高關注變異株|Variant of concern}}
**{{link-en|Variant of uncertain significance}}

== 参考文献 ==
{{reflist|30em}}

== 外部链接 ==
* [https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ WHO: Tracking SARS-CoV-2 variants] {{Wayback|url=https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ |date=20210606183718 }}
* [https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-emerging-variants.html Science Brief: Emerging SARS-CoV-2 Variants (CDC)] {{Wayback|url=https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-emerging-variants.html |date=20210610102326 }}
* [https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/variant-surveillance/variant-info.html SARS-CoV-2 Variant Classifications and Definitions (CDC)] {{Wayback|url=https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/variant-surveillance/variant-info.html |date=20210616060332 }}
* [https://www.gov.uk/government/publications/covid-19-variants-genomically-confirmed-case-numbers/variants-distribution-of-cases-data Variants of concern or under investigation: data up to 5 May 2021 (PHE)] {{Wayback|url=https://www.gov.uk/government/publications/covid-19-variants-genomically-confirmed-case-numbers/variants-distribution-of-cases-data |date=20210607111658 }}
* [https://www.ecdc.europa.eu/en/covid-19/variants-concern SARS-CoV-2 variants of concern as of 11 May 2021 (ECDC)] {{Wayback|url=https://www.ecdc.europa.eu/en/covid-19/variants-concern |date=20210616103810 }}
* [https://aci.health.nsw.gov.au/covid-19/critical-intelligence-unit/sars-cov-2-variants Living Evidence - SARS-CoV-2 variants] {{Wayback|url=https://aci.health.nsw.gov.au/covid-19/critical-intelligence-unit/sars-cov-2-variants |date=20210416012757 }}
* [https://www.nytimes.com/interactive/2021/health/coronavirus-variant-tracker.html Coronavirus Variants and Mutations] {{Wayback|url=https://www.nytimes.com/interactive/2021/health/coronavirus-variant-tracker.html |date=20211130040553 }}

{{Coronavirus}}
{{COVID-19}}
{{SARSr-CoV}}
{{Portal bar|2019冠状病毒病|病毒}}

[[Category:严重急性呼吸系统综合征冠状病毒2变异毒株|]]
[[Category:2019冠狀病毒病疫情相關列表|Category:2019冠狀病毒病疫情相關列表]]